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Abstract 
Concurrent with the well-documented motor speech production impairments in 
amyotrophic lateral sclerosis (ALS), individuals with ALS exhibit language problems 
including confrontation and generative naming difficulties, single word auditory and 
reading comprehension problems, and decreased self-regulation based on fewer self-
corrected utterances, among other language disruptions. Health related quality of life 
(HRQoL) measures specific to ALS often contain items related to its characteristic 
speech production problems that are thought to influence overall quality of life. 
However, the language problems in ALS are rarely if ever considered within the context 
of HRQoL. The current study aimed to identify the relationship between language 
problems (i.e., quality of communication) and HRQoL among individuals with ALS. 
Twenty-eight participants with ALS completed a general HRQoL (i.e., SF-36) and a 
quality of communication measure (i.e., ASHA QCL). Scores on these measures were 
compared with standardized language test scores and discourse measures including 
verbal fluency, the Boston Naming Test (BNT), and discourse measures obtained from 
a picture description task. Participants also completed a cognitive status and depression 
screening using the Montreal Cognitive Assessment (MoCA) and the Geriatric 
Depression Scale (GDS), respectively. The severity of ALS was measured using the 
ALS Functional Rating Scale.  Results indicated that verbal fluency (animals), discourse 
output, and speech intelligibility are associated with quality of communication.  
Regression analyses revealed important predictors of quality of communication 
including the BNT, MoCA, GDS, and speech intelligibility.  The only significant predictor 
for general HRQol (i.e., SF-36) was the GDS.  Results suggest that poor performance 
  iii 
on standardized language tests may not be indicative of poor quality of communication, 
however, findings show that poor efficiency on discourse tasks does affect quality of 
communication. Results also show that depression in individuals with ALS is associated 
with poor HRQoL. Overall physical functioning does not significantly contribute to quality 
of communication or overall HRQoL.  An important implication of the findings is that 
clinicians should focus on optimizing communication in those individuals with ALS who 
have poor speech intelligibility in order to optimize discourse output, which, in turn, may 
enhance the quality of communication in individuals with ALS. 
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Introduction 
ALS Background 
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease linked to cell death 
of lower motor neurons (LMN) of the brainstem and spinal cord, and upper motor 
neurons (UMN) of the cerebral cortex, leading to progressive paralysis of voluntary 
muscles and ultimately death.  The incidence rate of ALS in Canada is 2/100,000 (ALS 
Society of Canada, 2008).  Peak incidence rates occur between 50 and 70 years of age, 
with men affected more than women at a ratio of 1.6:1.0 (Eisen & Krieger, 1993; 
Mitchell & Borasio, 2007).  Although ALS most often affects those older than 40 years of 
age, 10% of cases involve patients younger than 40, and 5% of cases involve persons 
younger than 30 years of age (Shoesmith & Strong, 2006). ALS is a fatal disease, 
usually the result of respiratory failure where, following diagnosis, the mean length of 
survival in ALS ranges from 2.4 to 4.1 years (Boman & Meurman, 1967; Mulder & 
Howard, 1976).  However, twenty percent of individuals with ALS survive longer than 
five years and 10% survive longer than 10 years (Shoesmith & Strong, 2006). ALS is 
considered the third most common adult-onset neurodegenerative disease (Strong, 
Grace, Orange, & Leeper, 1996).  
There are different types of ALS. Sporadic ALS is the most common type and 
accounts for approximately 90% of ALS cases. In sporadic ALS, motor neurons 
degenerate and die prematurely from unknown causes. Familial ALS occurs in roughly 
10% of cases and usually results from an autosomal-dominant pattern of inheritance 
(Mitchell & Borasio, 2007; Shoesmith & Strong, 2006).  This inherited type of ALS 
typically has a younger age of onset and men are not more likely to develop it 
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(Mitsumoto, Chad, & Pioro, 1998).  Other than fact of inheritance, the two prominent 
types of ALS are clinically indistinguishable from one another (Mitsomoto et al., 1998).  
According to the World Federation of Neurology (1994), individuals diagnosed 
with ALS must show evidence of upper and lower motor neuron degeneration and 
demonstrate that the signs have spread within a distinct region of the body. Individuals 
diagnosed with ALS can first present with symptoms in the limbs, known as limb onset, 
or in bulbar regions (e.g., speech or swallowing), known as bulbar onset.  Shoesmith 
and Strong (2006) reported that approximately 75% of individuals with sporadic ALS 
present with limb-onset while approximately 21% present with bulbar onset.  Individuals 
with limb-onset ALS experience weakness in upper and/or lower extremities or truncal 
muscles while individuals with bulbar-onset ALS initially report weakness and changes 
in motor speech production and swallowing, known as dysarthria and dysphagia, 
respectively (Mitsumoto et al., 1998).  Bulbar ALS is localized within the corticobulbar 
area of the brainstem in early stages of ALS and exhibits a faster progression than the 
limb-onset form (Mitsumoto, 2009). Respiratory onset is an uncommon presenting 
feature in ALS.  However, the presence of impaired respiratory function is a negative 
prognostic factor (Stambler, Charatan, & Cedarbaum, 1998).  
Upper and lower motor neurons degenerate in both types of ALS (Mitsumoto et 
al., 1998). Degeneration of the upper motor neurons results in muscle stiffness and 
rigidity, hyperactive reflexes, and decreased ability to control laughing or crying.  
Pseudobulbar palsy results from degeneration of upper motor neurons in bulbar regions 
and in descending corticobulbar tracts (Mitsumoto et al., 1998).  Pseudobulbar palsy 
can result in exaggerated snout or jaw reflexes and spasticity of muscles, which cause 
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slow repetitive movements of the tongue (Brockington, Ince, & Shaw, 2006).  
Degeneration of the lower motor neurons results in muscle weakness and atrophy, 
involuntary twitching of muscle fibers (fasciculations), muscle cramps, decrease in 
muscle tone, weakened reflexes, difficulty swallowing (dysphagia), shortness of breath 
at rest (dyspnea), and difficulty speaking (dysarthria) (Brockington et al., 2006).  Lower 
motor neuron involvement results in flaccid or paretic bulbar palsy, in which there is 
wasting of the tongue musculature, a flaccid tone, and fasciculations (Darley, Aronson, 
& Brown, 1975; Mitsumoto et al., 1998). 
Weight loss due to amyotrophy, nutritional deficiencies and dysphagia are 
common clinical features in ALS. As well, individuals experience head drop, due to 
weakening of the neck muscles.  They also experience dyspnea and orthopnea, due to 
weakening of the respiratory muscles; and symptoms that result from nocturnal carbon 
dioxide retention (e.g., morning headache, anorexia, and daytime somnolence) 
(Mitsumoto et al., 1998). 
Speech Production in ALS 
Speech production in individuals with ALS can eventually becomes unintelligible 
as a result of the progressive degeneration of the oral, velopharyngeal, and laryngeal 
articulators (Bonduelle, 1975).  Individuals with ALS exhibit speech difficulties 
characterized as mixed flaccid-spastic dysarthria as a result of both upper and lower 
motor neuron degeneration (Darley et al.,1975).  Speech production in these individuals 
is characterized by imprecise consonants, hypernasality, harsh voice quality, slow 
speaking rate, monopitch, and short phrases.  These characteristics manifest slightly 
differently in each individual and occur at different times throughout disease progression 
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(Renout, Leeper, Bandur, & Hudson, 1995).  The progression of dysarthria leading to 
anarthria (inability to speak) contributes to communication difficulties in individuals with 
ALS (Darley, Aronson, & Brown, 1975).  In addition to dysarthria, communication in ALS 
also is affected by problems in cognition and language (Strong et al., 1999).  
Cognition in ALS 
The neural degeneration associated with ALS was once considered restricted to 
large motor neurons leaving cognition intact. However, it is now widely accepted that 
cognitive impairment exists in ALS, wherein it is classified as a multi-systems disorder 
with a wide range of cognitive problems (Strong et al., 1999).  The cognitive profile of 
individuals with ALS ranges along a continuum from no discernable cognitive deficits to 
severe dementia meeting diagnostic criteria for frontotemporal dementia (FTD) 
(Loemen-Hoerth et al., 2003; Neary et al., 1998).  Cognitive impairment (CI) in the 
absence of dementia is now recognized as a robust finding in individuals with ALS (Abe 
et al., 1997; Abrahams et al., 1997; Bak & Hodges, 1999; Gallassi et al., 1985; Gordon, 
et al., 2010; Hanagasi et al., 2002; Kilani et al, 2004; Lomen-Hoerth, et al., 2003; 
Raaphorst, DeVisser, Linssen, DeHaan, & Schmand, 2010; Strong et al.,1999).  The 
prevalence of CI in ALS sample populations is estimated to range from 35.6% to 50% 
(Massman, Sims, Cooke, Haverkamp, & Appel, 1996; Phukan et al., 2012; Ringholz et 
al., 2005).  In a population based study of 160 individuals with ALS, Phukan et al. 
(2012) found that 47% of individuals showed no discernable cognitive deficits, 21% 
exhibited a cognitive impairment including executive dysfunction, 14% possessed a 
cognitive impairment with no executive dysfunction (i.e., showed language or memory 
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deficits), 14% demonstrated ALS-FTD, and the remaining 4% displayed coinciding 
Alzheimer’s dementia or were unable to be categorized. 
The typical profile of CI in ALS includes disruptions to attention systems and 
processes, executive dysfunction, problems with multiple memory systems, and 
impaired visuospatial skills.  Deficits also manifest as declines in verbal and non-verbal 
fluency, working memory, cognitive flexibility, sustained attention, recognition memory 
for words and faces, visual perception, reasoning, word generation, word fluency, and 
executive functions such as planning, organizing, and self-monitoring (Abe et al., 1997; 
Abrahams et al., 2000; Elamin et al., 2011; Portet, Cadilhac, Touchon, & Camu, 2001; 
Strong et al., 1996; Strong et al., 1999, Talbot et al., 1995).  Portet et al. (2001) found 
that ALS disease severity was more pronounced when cognitive impairment was 
present.  Cognitive impairments in ALS are associated with shorter survival times 
(Elamin et al., 2011; Gordon et al., 2010).   
Whereas in some individuals with ALS cognitive dysfunction is undoubtedly due 
to the degenerative process associated with the disease, others exhibit cognitive 
dysfunction that is related to respiratory compromise.  Cognitive status in persons with 
ALS has been correlated with reduced vital capacity.  Kim et al. (2007) found that 
participants with a reduced vital capacity performed significantly poorer in memory 
retention, retrieval efficacy, and spoken verbal fluency than those participants with a 
normal vital capacity.  Individuals with ALS showed improved cognition as a result of 
using non-invasive positive pressure ventilation over six weeks (Newsom-Davis, Lyall, & 
Leigh, 2001).  The cognitive status is likely due to neuronal loss, gliosis, or sponginess 
in the hippocampus and parahippocampal regions that are vulnerable to hypoxia (Kato, 
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Oda, & Hayashi, 1994). Respiratory insufficiency can be identified using values of vital 
capacity, nasal inspiratory pressure, oxygen saturation, diaphragmatic amplitude, or 
blood gas levels (Hardiman, 2011). Low carbon dioxide-blood gas levels measured non-
invasively in arterialized venous blood using a transcutaneous earlobe monitor are 
considered the “gold standard” of respiratory insufficiency (Hardiman, 2011).  
In addition to respiratory compromises affecting cognition in ALS, there is a large 
body of evidence showing that depression affects cognition. For example, Lichetenburg, 
Ross, Millis, and Manning (1995) found a modest relationship between scores of 220 
older adults on the Geriatric Depression Scale (GDS) and two measures of cognition; 
the Dementia Rating Scale (DRS) and the Logical Memory Test.  The GDS scores were 
a consistently significant predictor of the DRS and Logical Memory scores.  The authors 
concluded that depression is an independent predictor of cognition.  Depression also 
can frequently be associated with executive deficits, which in turn, can influence 
participants’ performances in high-level language processing or verbal fluency tasks, 
which are largely dependent on executive functions (Starkstein, Bolduc, Mayberg, 
Preziosi, & Robinson, 1990).  Prevalence rates for depression in individuals with ALS 
range from 0% to 44%, but studies using the structured interview according to DSM-IV 
criteria for depression find highly consistent rates of 9 to 11% (Kurt, Nijboer, Matuz, & 
Kubler, 2007).  More recently, McElhiney, Rabkin, Gordon, Goetz, and Mitsumoto 
(2012) found that, in a sample of 223 individuals with ALS, only 7% (16/223) had major 
or minor depression and that the depression was not associated with ALS severity.   It is 
prudent to take into account the presence of depressive symptoms when evaluating 
language abilities in individuals with ALS. 
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A diagnosis of dementia requires multiple cognitive deficits of gradual onset and 
continual decline, which include both memory and any one or more of the following: 
language problems, movement programming problems, agnosia, or disturbance in 
executive functioning (DSM –IV TR, 2000).  These impairments must cause significant 
impairment in social or occupational functioning and must represent significant decline 
from previous functioning.  In addition, deficits cannot be caused by other central 
nervous system (CNS) conditions, systemic conditions known to cause dementia, 
substance abuse, delirium, or any other primary psychiatric disorder (DSM IV-TR, 
2000).  
Frontotemporal-type dementia (FTD) is the most common type of dementia in 
ALS (Bak & Hodges, 1999).  FTD is defined as a behavioural syndrome marked by 
profound alternations in personality and social conduct, inertia and loss of volition or 
social disinhibition, with a relative preservation of memory (Neary et al., 1990).  The 
term FTD is restricted to the overall clinical spectrum of frontotemporal dementia 
including behavioural variant FTD (bvFTD), and three variants of primary progressive 
aphasia (PPA). The term frontotemporal lobar degeneration (FTLD) is restricted to the 
neuropathological correlate of FTD (Strong, 2008).  
Symptoms of FTD include disinhibition, impulsivity, changes in sleep and eating 
patterns, decreased attention, decreased executive functioning and planning, apathy, 
and poverty of speech production and spoken language progressing to mutism (Neary 
et al., 1990). ALS-frontotemporal dementia (ALS-FTD) is estimated to occur in three 
percent of sporadic cases and 15% of the familial type (Bak & Hodges, 1999; Loemen-
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Hoerth et al., 2003).  ALS-FTD is a negative prognostic indicator including shortened 
disease duration with more severe symptom presentation (Elamin et al., 2011).  
Any variant of FTD can be associated with ALS, however, the behavioural variant 
FTD (bvFTD) and nonfluent variant primary progressive aphasia (nfvPPA) are most 
commonly associated with ALS, because they are localized to the frontal lobes of the 
cortex near the motor strip.  Individuals with ALS can display signs and symptoms of 
each variant of PPA that occur within the clinical syndrome of FTD; nfvPPA, semantic 
variant PPA (svPPA), or logopenic variant PPA (lvPPA).  nfvPPA is sometimes the first 
clinical diagnosis in those who develop ALS-FTD (Bak, O’Donovan, Xuereb, Boniface, & 
Hodges, 2001; Lomen-Hoerth et al., 2003; Strong, 2008).  Although language deficits 
are common in ALS, it is debatable whether these deficits are strictly language 
impairments or part of an underlying cognitive impairment (South, Findlater, Strong, & 
Orange, 2012). 
Language in ALS 
Individuals with ALS exhibit language impairments in the absence of CI or FTD.  
The language performances of individuals with ALS have been studied in combination 
with other neuropsychological batteries as part of general cognitive testing in ALS 
(Cobble, 1998).  Language deficits of individuals with ALS without CI or FTD most 
commonly include word retrieval problems (Abrahams et al., 2004; Abrahams, Leigh, & 
Goldstein, 2005; Mantovan et al., 2003; Racowicz & Hodges, 1998; South, Findlater, 
Strong, & Orange, 2011; Strong et al., 1999). Naming deficits occur in both category 
verbal fluency tasks (e.g., naming animals) and letter verbal fluency tasks (e.g., naming 
words that begin with the letter “F”) (Abrahams et al., 2000; Hanagasi et al., 2002; 
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Strong et al., 1999) along with problems in confrontation naming (Abrahams et al., 
2004; Hanagasi et al., 2002; Mantovan et al., 2003; Ringholz et al., 2005; Strong et al., 
1999).  Reduced single-word vocabulary comprehension (Strong et al., 1999), impaired 
auditory comprehension (Mantovan et al., 2003), and verbal and semantic paraphasias 
on confrontation and noun naming tasks (Cooper et al., 2008; Strong et al., 1999) also 
are overall common features of the language profile of individuals with ALS.  Abrahams 
et al. (2005) found impairments in both spoken and written verbal fluency tasks in ALS 
participants without dementia. However, the verbal fluency did not change over time. 
This suggests that verbal fluency impairments in ALS may result from higher order 
cognitive dysfunction, indicating deficits in attention systems or central executive 
component of working memory (Abrahams et al., 2004).  It is important to note that 
among normal individuals, it is not until they are generally over the age of 75 that they 
experience word retrieval problems and difficulties on confrontation and generative 
naming tasks associated with aging (Goodglass, 1980; Nicholas, Barth, Obler, Au, & 
Albert, 1997).  Executive functioning (i.e., planning, organizing, and reasoning) and 
episodic memory also are affected by aging. Typically, recall of information is affected 
more than the ability to recognize previously seen or heard information (Nyberg et al., 
2003).   
Individuals with ALS without CI or without FTD demonstrate decreased self-
regulation with fewer self-corrected utterances during discourse (South et al., 2011; 
Strong et al., 1999).  Narasimha (2009) also showed that individuals with ALS without 
CI or without FTD produce more simplified verb structures, as well as more 
parenthetical remarks, suggesting possible word retrieval or language deficits.  Using 
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the same discourse measures, South et al. (2011) showed differences in word finding 
indices of word retrieval in individuals with ALS compared to controls.  Reduced 
discourse efficiency in the South et al. (2011) study was hypothesized to be due to 
presence of revisions and reformulations (i.e., “[He is] [she is climbing] she was 
reaching for a cookie,”) or to the presence of “empty words” which do not enhance the 
content (e. g. “The [thing] it is somewhat a [you know thing]”).  Word retrieval problems 
may underscore the reduced discourse efficiency seen at all time points in the study.  
Strong et al. (1999) also tested communication during discourse in ALS using a topic-
directed interview (TDI) protocol, based on Ripich and Terrell (1988), at two times 
periods over six months.  Results indicated that individuals with ALS produced 
significantly fewer self-corrected utterances than did controls at the six-month period. 
Two longitudinal studies addressed the progression of language impairment 
without dementia throughout the course of ALS (Abrahams et al., 2005; Strong et al., 
1996).  In both studies, participants were tested at baseline and again six months later.  
Strong and colleagues (1996) did not find any significant differences in the language 
performances of their participants over time.  Abrahams and colleagues (2005), 
however, found evidence of significantly slower word retrieval times for the participants 
with ALS on the Computerised Sentence Completion test at the six-month follow up 
period. 
Structural and functional brain imaging changes correlate strongly with cognitive 
and language impairments in individuals with ALS (Abrahams et al., 2004; Bak & 
Hodges, 2004; Kew et al., 1993). Cognitive and language impairments may be 
secondary to neuronal loss in the cortex throughout disease progression. Using PET 
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imaging, Abrahams et al. (1997) reported that individuals with ALS who exhibited 
deficits in verbal fluency demonstrated cortical and subcortical dysfunction.  These 
deficits affected the frontal lobes with extension into the insular cortex and thalamic 
nuclei. Abrahams et al. (2004) studied letter fluency, category fluency, and picture 
confrontation naming in 28 ALS participants and 18 controls in conjunction with fMRI.  
The letter fluency task was associated with reduced activation in extensive regions of 
the left prefrontal cortex, left temporal lobe, left parietal lobe, and right anterior cingulate 
gyrus. Increased activation was found in the right inferior frontal gyrus, right middle 
temporal gyrus, and left superior frontal gyrus.  During the confrontation-naming task, 
there was impaired activation in the left prefrontal cortex, right inferior frontal gyrus, right 
cingulated gyrus, left temporal lobes, bilateral parietal lobes, and occipital lobes.  
Although language deficits in ALS are evident, it is unclear whether these deficits are 
part of an underlying cognitive impairment or strictly linguistic in nature (South et al., 
2011).  Recent evidence suggests that executive dysfunction impairments do not 
underscore the language problems in ALS (Taylor et al., 2012). Language impairments 
in individuals with ALS without CI or without dementia may be an under recognized 
feature of ALS and can progress over time.  
Individuals with ALS-FTD display various language impairments (Hayley & 
Ramer, 2000). These include impaired comprehension for both complex sentences and 
single word semantic processing tasks, as well as reading and writing difficulties 
(Caselli, et al., 1993; Cobble, 1998; Hayley & Ramer, 2000; Rakowicz & Hodges, 1998). 
ALS-FTD affects word retrieval, language comprehension, and spelling (Bak & Hodges, 
1997, 2004; Neary et al., 1990; Rakowicz & Hodges, 1998). Individuals with ALS-FTD 
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ranged from normal, to mildly impaired to echolalic on tests of verbal repetition 
(Cavelleri & DeRenzi, 1994; Neary, et al., 1990).  Impairments also are prominent for 
nouns and verbs on both naming and comprehension tasks, with increased difficulty for 
verbs (Bak & Hodges, 1997, 2004; Hillis, Oh, & Ken, 2004). Bak and Hodges (2004) 
reported that language deficits might be an early and prominent feature of individuals 
with ALS-FTD.   
Quality of Life (QoL) in ALS 
The World Health Organization (1994) defines QoL as, “the individual’s 
perception of their [sic] position in life in the context of culture and value systems in 
which they [sic] live and in relation to their [sic] goals, expectations, standards and 
concerns” (p. 1).  “QoL is a broad ranging concept affected in a complex way by the 
persons’ physical health, psychological state, level of independence, social relationships 
and their relationship to salient features in their environment” (WHO, p.1).  QoL is 
determined by considering heath-related factors (physical, functional, emotional, and 
mental-wellbeing) and non-health-related factors (jobs, family friends, spirituality, and 
other life circumstances) (Burns, Graham, Rose, & Simmons, 2012). 
Physical status has been shown to be less relevant in determining overall QoL in 
ALS, wherein QoL remains stable while physical function declines (Chio et al., 2004; 
Lulé, Häcker, Ludolph, Birbaumer, & Kübler, 2008; Nygren & Askmark, 2006; Robbins, 
Simmons, Bremer, Robbins, Walsh, & Fisher, 2001).  Tramonti, Bongioanni, Di 
Bernardo, Davitti, and Rossi (2012) found that participants’ self-perceived quality of life, 
measured by the Schedule for the Evaluation of Individual Quality of Life Direct 
Weighting Scale (SEIQoL-DW), was not correlated with any scores of physical 
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functioning or depression, confirming previous findings emphasizing how the subjective 
perception of life satisfaction is not necessarily related to physical functioning and even 
to HRQoL.  The Amyotrophic Lateral Sclerosis Functional Rating Scale (ALS-FRS), a 
measure of disease severity, score is not a predictor of QoL.  However, depression 
severity is correlated with lower QoL scores in those with ALS (Krampe et al., 2008).  
The QoL of 26 individuals with ALS, as assessed by participants’ responses to the 
McMaster QoL (Sterkenburg, King, & Woodward, 1996) scale every four to seven 
months did not change significantly over a 24-month follow up period (Nygren & 
Askmark, 2006).  Using the same QoL scale, Roach, Averill, Segerstrom, and Kasarski 
(2009) found that the effect of time did not affect the QoL of individuals with ALS. 
However, the total QoL, and in particular QoL related to physical symptoms of 
individuals with ALS, declined over time for their caregivers.  Lule et al. (2008) did not 
find any correlation between physical disability in ALS and either depression or self-
perceived QoL (SEIQoL-DW).  The severity of depression in this study was inversely 
related to educational status, and QoL of these individuals with ALS was comparable to 
healthy controls.  Individuals with ALS experienced a satisfactory QoL without 
depressive manifestations even if they were severely physically impaired, including 
those who were in the terminal phases of the disease.    
Goldstein, Atkins, and Leigh (2002) found that global self-ratings of individuals 
with ALS, measured by the SEIQoL-DW (O’Boyle, 1994), were correlated positively with 
scores on a self-report measure of cognitive functioning called the Short Inventory of 
Mental Lapses (SIML).  In this instance, greater self-rated cognitive impairment was 
related to poorer perceptions of QoL. The authors noted, however, that with more 
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cognitive impairment, the use of the SEIQoL-DW might be invalidated. since its 
completion requires the participant to have insight, to think about abstract concepts, to 
make judgments, and to use visual analogue scales.  The investigators also found that 
there is no correlation between SEIQoL-DW scores and any of the measures of physical 
or functional status as measured by the ALS Severity Score (ALSSS) or the Sickness 
Impact Profile (SIP). Anxiety or depression scores were not significantly correlated with 
SEIQoL-DW scores, indicating that mood did not influence self-perceived QoL scores.  
The researchers concluded that cognitive functioning also should be considered when 
evaluating QoL in ALS. 
The presence of neurobehavioural symptoms associated with ALS-FTD 
correlates significantly with lower caregivers’ QoL, higher caregiver depression, and 
higher caregiver burden, which can have profound impacts on caregivers’ emotional 
status (Chio, et al., 2010).  A low level of QoL in participants with ALS is thought to be 
due to pre-existing individual differences, whereas age and disease progression are 
likely to affect QoL among ALS caregivers (Roach et al., 2009).  Grehl, Rupp, Budde, 
Tegenthoff, and Fangerau (2011) found that self-ratings of QoL by individuals with ALS 
vs. their relatives perceived ratings of QoL for their relative with ALS are not statistically 
different using the Munish Quality of Life Dimensions List (MLDL) (von Steinbüchel, 
Bullinger, & Kirchberger, 1999). 
More research has been completed in HRQoL and other neurodegenerative 
diseases.  In a study of individuals with Parkinson’s disease (PD), Schrag, Jahanshahi 
and Quinn (2000) found that the spheres of daily living that deteriorated with advancing 
disease are associated predominately with mobility, self-care, activities of daily living, 
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physical and social functioning on generic measures of QoL such as the SF-36 (Ware & 
Sherbourne, 1992) and the EuroQoL (The EuroQoL Group, 1990).  However, when 
participants with PD completed a disease-specific QoL measure, the PDQ-39 
(Jenkinson & Fitzpatrick, 2007), cognition, communication, and bodily discomfort lower 
QoL scores significantly.  Ross and Wertz (2003) found that individuals with chronic 
aphasia could be distinguished from persons who do not exhibit aphasia based on 
different facets of QoL. These facets include level of independence, social relationships, 
and environment.  Ross and Wertz (2003) suggested that, to enhance QoL in 
individuals with language impairments such as those with chronic aphasia, therapy 
should focus on situation-specific communication and societal participation.  Although 
individuals with PD and aphasia do not exhibit the same communication difficulties as 
individuals with ALS, some of the features of these diseases are similar to features in 
ALS. 
Health Related Quality of Life (HRQoL) in ALS 
HRQoL is defined as, “the value assigned to the duration of life as modified by 
social opportunities, perceptions, functional states and impairments that are influenced 
by disease, injury, treatment, or policy and should include some assessment of general 
wellbeing and satisfactions with treatment, outcome, and health status with future 
prospects” (O’Boyle & Waldron, 1997, p. 3).  HRQoL is a more narrow term than QoL, 
although the terms have been used interchangeably, on occasion, in the literature. 
HRQoL often is viewed from more of a medical perspective, and so it often does not 
include factors such as family, support systems, religiosity, or income, unless these 
domains are directly affected by the health status of the individual.  HRQoL differs from 
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QoL in that it addresses issues that are related to the presence of disease or to the 
treatment of disease (Burns et al., 2012).  The devastating physical and emotional 
effects of ALS have detrimental impacts on the HRQoL of those with ALS as well as on 
the HRQoL of caregivers, family, and friends. 
 It has become increasingly important to use HRQoL measures to assess the 
improvement of health care services and to incorporate patient based outcomes to 
provide patient-centered baseline for assessment and treatment of various health 
conditions (Mitsumoto & Del Bene, 2000).  For example, scores on the ALS-specific 
HRQoL scale (SIP/ALS-19), which are primarily based on physical function, decline in 
parallel with scores on the ALS-Functional Rating Scale (ALS-FRS), a disease severity 
measure (Robbins et al., 2001).  Tramonti, et al. (2012) also found an overlap in the 
domain of physical functioning when comparing scores on the physical functioning 
subscale of the SF-36 and the ALSFRS-R.  Kiebert et al. (2001) asked individuals with 
ALS who were at different stages of the disease to complete a visual analogue scale of 
their own health rating and to complete a ALS-specific health status measure (ALSAQ-
40) (Jenkinson, Brennan, Fitzpatrick, Bromberg, & Swash, 1999) to measure HRQoL. 
They found that HRQoL decreases systematically with disease severity.  Olsson 
Oazanne, Strang, and Persson (2011) compared the scores from individuals with ALS 
and their next of kin on the Short-Form 36 (SF-36) a general HRQoL measure vs. the 
scores from a subset of a general Swedish population.  A strong correlation was found 
in both the mental component summary in SF-36 and in scores related to anxiety 
between the groups of participants and their next of kin. There were no significant 
correlations for the physical component summary scores or the depression scores 
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between the groups of participants and their next of kin. Findings showed that the 
HRQoL socres are not related to the physical function of the participants with ALS. Both 
individuals with ALS and their next of kin exhibited some poorer ratings on the SF-36 
and on measures of anxiety and of depression than did those from the general Swedish 
population. Gender or age did not affect the estimates in any of the scales.  Chio et al. 
(2004) concluded that HRQoL measures may not be adequate to assess overall QoL in 
ALS because QoL in ALS depends on psychological, supportive, and spiritual factors.  
Interestingly, although HRQoL in individuals with ALS declines over time, self-rated 
global QoL, does not appear to do so (Burns et al., 2012).   
QoL and HRQoL are difficult concepts to measure, especially among individuals 
with ALS.  Some of the QoL and HRQoL measures are disease specific while others are 
generic and not disease specific in nature.  A disease-specific vs. a general measure of 
the quality of life, and vice-versa, will be appropriate depending on the purpose and the 
objectives of the study (Burns et al., 2012).  
Statement of the Problem 
Health care providers can underestimate the QoL and HRQoL of individuals with 
chronic diseases and often can make assumptions about the importance of strength 
and physical ability (Olsson et al., 2010).  Many of the scales used to evaluate QoL and 
HRQoL in ALS are generic in nature and items therein often are not specific to the 
disease per se (Bromberg & Forshew, 2001).  Moreover, there are few disease specific 
QoL and HRQoL measures for persons with ALS and none that contain items that 
address communication problems; problems that are now well recognized in published 
studies on the cognitive and language impairments in ALS (Paul et al., 2004).   
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The determinants of HRQoL in ALS are unclear.  The relationship between 
HRQoL and communication impairments in ALS needs to be explored, where current 
evidence shows that psychological and social issues in ALS affect HRQoL more 
severely than do physical symptoms alone.  The communication of individuals with ALS 
is impaired in both the severity of their dysarthria and their language and cognitive-
communication deficits.  The impact of language deficits on quality of communication in 
those with ALS remains to be explored.  It is expected that individuals with ALS who 
exhibit language or cognitive impairments will display lower HRQoL than individuals with 
ALS who are not affected by any language or cognitive deficits. 
Objectives 
The objective of this study is to determine whether language and speech 
intelligibility impairments in individuals with ALS are associated with poor self-perceived 
quality of communication and overall HRQoL.  
Research Questions 
The following research questions are posed for this study. They are: 
RQ 1 Language and Quality of Life Measures 
What is the association between language scores on the Boston Naming Test (Kaplan, 
Goodglass, & Weintraub, 1983), verbal fluency (i.e., animals), and measures of 
language output from the Cookie Theft description task (Boston Diagnostic Aphasia 
Examination – BDAE – 3rd edition) (Goodglass, Kaplan, & Baressi, 2001) and: 
a) Self-Rated Quality of Communication (ASHA QCL measure) (Paul et al., 
2004)? 
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b) Self-Rated Health Related Quality of Life (SF-36 measure) (Ware & 
Sherbourne, 1992)? 
RQ 2 Speech Intelligibility and Quality of Life Measures 
What is the correlation between perceived speech intelligibility ratings and: 
a) Self-Rated Quality of Communication (ASHA QCL measure) (Paul et al., 
2004)? 
b) Self-Rated Health Related Quality of Life (SF-36 measure) (Ware & 
Sherbourne, 1992)? 
RQ 3 Speech Intelligibility and Language Measures  
What is the correlation between perceived speech intelligibility ratings and language 
scores on the BNT, verbal fluency (animals), and measures of language output from the 
Cookie Theft description task? 
RQ 4 Predictors 
What are the relative contributions of the BNT, MoCA, GDS, speech intelligibility, and 
the ALSFRS-R to: 
a) Self-Rated Quality of Communication (ASHA QCL) (Paul et al., 2004)? 
b) Self-Rated Health Related Quality of Life (SF-36) (Ware & Sherbourne, 1992)? 
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Method 
Participants 
Twenty-eight participants with a diagnosis of probable or definite ALS defined by 
the El Escorial diagnostic criteria (1995) for ALS were recruited as a convenience 
sample from the London Health Sciences Centre (LHSC) Motor Neuron Disease Clinic 
at University Hospital in London, Ontario led by neurologist Dr. Christen Shoesmith 
(CS).  All participants were between 38 to 74 years of age with a mean of 59.25 years 
(+/- 9.62 SD), and spoke and understood English as their first language.  All 28 
participants self-reported normal and functional vision and hearing. Participants were 
excluded if they had a history of other neurologic or psychiatric conditions that affect 
cognition and language performance (e.g., major hemispheric stroke, traumatic brain 
injury, learning disability, epilepsy, alcohol dependence syndrome, severe mental 
illness, use of high-dose psychoactive medication, or evidence of FTD according to 
Neary et al. (1998) criteria and Strong et al. (2009) criteria. Participants were not 
excluded based on cognitive or depression screening, and instead cognition and 
depression scores were factored into the analyses.  It was thought that not enough 
participants in the MND clinic would be eligible to participate in this study if such strict 
exclusion criteria were used.  Participants also were excluded if they exhibited a PCO2 
level greater than 50 mmHg within three months of participation, as determined by chart 
review. Table 1 displays the demographic characteristics of the participants with ALS.  
No controls were used in this study. 
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Table 1  
Demographics of participants with ALS (N=28) 
Characteristics and Tests Mean SD Range 
Age (yrs) 59.3 9.61 43-74 
Education (yrs) 14.2 2.7 7-19 
Handedness (27 R: 1 L)    
Gender (17 Men: 11 Women)    
MoCA (max 30) 24.6 3.4 16-30 
GDS (max 30) 7.8 4.8 2-22 
ALSFRS-R (max 48) 30.9 9.7 14-45 
     Speech subtest (max 4) 2.7 1.0 1-4 
Note. MoCA = Montreal Cognitive Assessment, GDS = Geriatric 
Depression Scale, ALSFRS-R = ALS-Functional Rating Scale Revised 
 
Procedure 
This study of individuals with ALS was a cross-sectional in design.  All testing 
was video and audio digitally recorded using a Canon™ VIXIA HFM500 video camera 
and a Rode™ Videomic Pro Compact Shotgun Microphone.  Data were collected in one 
session lasting approximately 1.5 hours.  Data were collected in the research room of 
the Motor Neuron Diseases unit on the seventh floor at the LHSC-UH site (n=15) or in 
participants’ homes (n=13).  Data were collected by the author (KMF) and her research 
supervisor (JBO) (n=19) or by the author herself (n=9). Written consent was obtained 
from each participant. This study was authorized by the Office of Research Ethics at 
Western University (HSREB code #102807).  A Data Transfer Agreement with Lawson 
Health Research Institute was also granted for this study (See Appendix A for the Letter 
of Information, Letter of Consent, HSREB authorization form, Lawson Health Institute 
Approval, and Data Transfer Agreement).  
ALS participants first completed the Cookie Theft picture description task from 
the Boston Diagnostic Aphasia Examination – 3rd Edition (Goodglass, Kaplan & Baressi, 
  22 
2001) to obtain a language sample suitable to calculate measures of correct content 
units and measures of content efficiency. The purpose of collecting these measures 
was to obtain a sample that was representative of each participant’s spontaneous 
discourse output given the same picture to describe.  
Productivity measures for the language samples included total words, total 
utterances, and mean length of utterance (MLU). Words were defined according to the 
criteria described by Nicholas and Brookshire (1993), including intelligible words within 
context but which are not required to be accurate, relevant, or informative relative to the 
topic being discussed. For example, filler words such as, “you know”, “I mean” or 
interjections such as “oh, wow, golly, gosh, and gee” were counted.  Words or partial 
words that were intelligible in context such as, “The moth mother,” for example, were 
not counted.  Non-filler words, such as, “um, er, uh, hmm, and mmm,” were not 
counted.  Utterances were defined as a group of words expressing a complete thought 
separated from other utterances based on content shifts, intonation changes, and/or 
pauses (Shewan, 1988). Mean length of utterance was defined as described in 
Retherford (1993).   
Discourse measures of content including Correct Information Units (CIUs) were 
defined using the definition of Nicholas and Brookshire (1993).  CIUs were defined as 
those words that were intelligible in context, accurate to picture/topic content, and 
relevant to picture/topic content.  The number of different novel concepts used to 
describe the picture was determined using content units (CUs), based on the method 
reported by Yorkston and Beukelman (1980).  CUs reflect participants’ abilities to 
deduce information from the Cookie Theft picture. A second content efficiency measure 
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was calculated by dividing the number of CU by the total number of words to generate 
the measure of words per CU.  None of the 28 participants were anarthric, as each 
participant was able to complete the task verbally. 
After the discourse sample was obtained, the content was transcribed 
orthographically and segmented into utterances by the author (KMF) and a trained but 
naïve assistant (undergraduate student) who did not know the purpose of the study. 
Reliability scores for words for intra- (all samples) and inter-transcriber agreement 
studies (5 transcripts = 17.8% of transcripts for the naïve transcriber) were calculated 
using Cronbach’s alpha and were (α = .999) and (α = .997), respectively.  Reliability 
scores for utterance segmentation for intra- (all samples) and inter-transcriber 
agreement studies (5 transcripts = 17.8% of transcripts for the naïve transcriber) were 
calculated using Cronbach’s alpha and were (α = .997) and (α = .995), respectively.  
Reliability scores for correct information units for intra- (all samples) and inter-
transcriber agreement studies (5 transcripts = 17.8% of transcripts for the naïve 
transcriber) were calculated using Cronbach’s alpha and were (α = .998) and (α = .898), 
respectively.  Reliability scores for Content Units for intra- (all samples) and inter-
transcriber agreement studies (5 transcripts = 17.8% of transcripts for the naïve 
transcriber) were calculated using Cronbach’s alpha and were (α = .997) and (α = .982), 
respectively.    
Participants with ALS also completed standardized language tests including a 
30-item short-version of Boston Naming Test (BNT) (Kaplan et al.,1983).  The BNT is a 
60-item test in which participants are shown black-line drawings of nouns and are asked 
to name those nouns.  The purpose of using the BNT in this study was to assess 
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participants’ abilities on confrontation noun naming, which can be impaired in ALS.  
Participants also completed seven measures of verbal fluency, including four categories 
of living items (i.e., animals, breeds of birds, breed of dogs, and water creatures) and 
three categories of non-living items (i.e., methods of transportation, musical 
instruments, and tools).  These categories are based on an adapted version of the 
Hodges, Salmon, and Butters (1992) category fluency task conducted with individuals 
with Alzheimer’s disease.  All participants with ALS were asked to generate verbally as 
many items as they could in one minute for each of the seven categories.  One 
participant was allowed to respond in written form due to severe motor speech 
impairment.  An additional 30 seconds was provided to the participant for the first 
category (animals).  In the first 60-second period of the animals category she produced 
a normal number of exemplars and did not write any additional exemplars in the extra 
30 seconds that were provided.  Given her performance on this category, it was decided 
that she did not need additional time to complete the written task. She was allowed 60 
seconds for each remaining category. The purpose of the verbal fluency task was to 
assess participant’s ability in generative noun naming when given a category, which has 
been shown to be impaired in most individuals with ALS.  
Participants with ALS then completed the Geriatric Depression Screening Scale 
(GDS), a 30-item, self-rated depression scale specifically designed for identifying and 
rating depression in older adults (Yesavage & Brink, 1983). The GDS is reliable and 
valid in rating depression among adults with and without dementia (Stiles & 
McGarrahan, 1998). The GDS questions are answered using "Yes" or "No" responses. 
The binomial response option enables those who are ill or who suffer a mild or 
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moderate cognitive impairment to complete the measure with relative ease.  The scale 
is used commonly as a routine part of a comprehensive geriatric assessment (Koenig, 
Meador, Cohen, & Blazer, 1988).  One point is assigned to each answer that indicates 
depression and the cumulative score is rated on a scoring grid. The grid sets a range of 
0 to 9 as "normal", 10 to 19 as "mildly depressed", and 20 to 30 as "severely depressed" 
(Lesher & Berryhill, 1994).  One participant scored 22/30 on the GDS, indicating severe 
depression.  The participant’s attending neurologist (CS) was notified about the score 
on this measure.  All other 27 participants had scores on the GDS that indicated they 
did not suffer from severe depression.  The purpose of using the GDS in our study was 
to screen for individuals in the study who may be affected by depression, which could 
affect their scores on other tests of cognition and language, such as the MoCA and SF-
36.  
Participants with ALS then completed the MoCA (Nasreddine et al., 2005).  The 
MoCA is a screening instrument designed to detect mild cognitive dysfunction. The 
MoCA has well established and robust validity and reliability psychometric properties 
(Nasreddine et al., 2005). The MoCA contains tasks designed to assess attention and 
concentration, executive functions, memory, language, visuoconstructional skills, 
conceptual thinking, calculations, and orientation. It takes approximately 10 minutes to 
administer the MoCA. The maximum possible score is 30 points; a score of 26 or above 
is considered normal (Nasreddine et al., 2005).  Adjustments in administration and 
scoring were made in accordance with published criteria for participants with clinically 
significant motor impairments (Nasreddine et al., 2005). One point was added to the 
total score if the participants’ education was less than or equal to 12 years, as is 
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standard in MoCA testing (Nasreddine et al., 2005).  There were ten participants who 
were unable to write due to physical limitations.  These individuals, completed the trail-
making task of the MoCA verbally.  These same individuals who were unable to write, 
were unable to complete the cube drawing and clock drawing subtests of the MoCA.  
These individuals could only obtain a maximum score of 26.  All of the MoCA scores for 
each of the 28 participants were converted into percentage scores to account for the 
differences in total possible items correct (26 or 30).  The MoCA was administered in 
this study to identify those participants who might possess mild cognitive impairment.   
Participants with ALS also completed a general health related quality of life 
(HRQoL) measure called the Short Form 36 (SF-36) (Ware & Sherbourne, 1992), and 
the American Speech and Hearing Society’s Quality of Communication Scale (ASHA 
QCL) (Paul et al., 2004).  The SF-36 is a self-administered general measure of HRQoL, 
which focuses on physical and mental aspects. It consists of 36 items in eight health 
domains; (1) limitations in physical activities because of health problems, (2) limitations 
in social activities because of physical or emotional problems, (3) limitations in usual 
role activities because of physical health problems, (4) bodily pain, (5) general mental 
health (psychological distress and well-being), (6) limitations in usual role functioning 
because of emotional problems, (7) vitality (energy and fatigue), and (8) general health 
problems (Ware & Sherbourne, 1992).  Participants record responses using a Likert 
method of summated ratings.  The SF-36 takes approximately 10 to 15 minutes to 
complete. Scores are translated to a scale from 0 to 100, where higher scores represent 
a higher (i.e., better) HRQoL.  The SF-36 was chosen as a generic HRQoL measure 
because of its robust use with the ALS population, and its overall strong reliability and 
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validity psychometric properties in the general population and in several different 
disease groups (e.g., stroke, multiple sclerosis, and cancer).  Scores on the SF-36 are 
normalized such that a score of 50 becomes the average score and the norm.  This 
norm-based score enables comparison across more than 17,000 studies in the last 20 
years (Calsyn et al., 2004). The SF-36 displays good internal consistency (>0.80 in all 
dimensions except social functioning, 0.68) (Gandek et al., 2004; McCallum, 1995; 
McHorney, Ware, Lu, & Sherbourne, 1994; Stevenson, 1996; Ware, Kosinski, & Keller, 
1994).  It possesses adequate test-retest reliability (>0.70 in all studies) (Bowling, 1995; 
Hopman et al., 2004; Kagee, 2001; Sanson-Fisher & Perkins, 1998; Ware et al., 1994). 
Inter-rater reliability has not been measured because it is a self-administered tool.  The 
SF-36 also is a very valid instrument.  Studies showed that it possesses adequate 
discriminatory power (Kagee, 2001; Komaroff et al., 1996), good correlation with other 
measures (0.19-0.69 across domains) (Beaton, Hogg-Johnson & Bombardiner, 1997; 
Calsyn et al., 2004; Essink-Bot, Krabbe, Bonel, & Aaronson, 1997; Prieto, Alonson, 
Ferrer, & Anto, 1997), good construct validity (>0.70) (Jenkinson, 1999; Ware et al., 
1995, 1998), and good criterion validity (>0.70) (Elliott, Renier, & Palcher, 2003; Kagee, 
2001; Jenkinson, Wright & Coulter, 1994).  The SF-36 also is sensitive to change, 
(Jenkinson, Lawerence, McWhinnie, & Gordon, 1995; Jenkinson et al., 1997; Sharples, 
Todd, Caine, & Tait, 2000), is translated into many languages and its content can be 
administered cross-culturally (Perneger, Lepledge & Etter, 1999; Wagner et al., 1998).  
The SF-36 has been used in previous studies designed to examine determinants of 
HRQoL in individuals with ALS (Neudert, Wasner, & Borasio, 2004; Olsson Orzanne et 
al., 2011; Swash, 1998).  However, with only a few questions in the SF-36 that address 
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communication and social interaction, the American Speech and Hearing Association’s 
Quality of Communication Life Scale (ASHA QCL) was completed by participants in this 
study to provide greater detail about the factors of communication and language 
impairments that load onto overall QoL in individuals with ALS.  The ASHA QCL 
possesses adequate reliability and validity across a population of 85 individuals with the 
following conditions: aphasia due to left or right-hemispheric stroke, cognitive 
communication disorder due to traumatic brain injury, and dysarthria due to an acquired 
progressive neurological disease such as Parkinson’s disease, Multiple Sclerosis, and 
ALS (Paul et al., 2004).  Although the ASHA QCL has not been widely cited in the 
literature, it was chosen for this study because of its communication context.  The 
purpose of using the ASHA QCL was to access participant’s self-rated quality of 
communication. 
Lastly, ALS disease severity was measured using the ALS-Functional Rating 
Scale- Revised (ALSFRS-R) (Cedarbaum et al., 1999).  The ALSFRS-R is a validated 
rating instrument for monitoring the progression of disability in patients with ALS.   The 
original ALSFRS had a disproportionate weighting toward limb and to bulbar onset vs. 
respiratory dysfunction. It is now validated as a revised version of the ALSFRS-R, which 
incorporates additional assessments of dyspnea, orthopnea, and the need for ventilator 
support. The Revised ALSFRS (ALSFRS-R) retains similar psychometric properties of 
the original scale and shows strong internal consistency and construct validity.  
ALSFRS-R scores correlate significantly with quality of life as measured by the 
Sickness Impact Profile, indicating that the quality of function is a strong determinant of 
quality of life in ALS (Cedarbaum et al., 1999).  The purpose of using the ALSFRS-R 
  29 
was to assess participant’s disease severity, which can widely vary from individual to 
individual within the ALS population. Disease severity could affect scores on other 
measures of HRQoL such as the SF-36. 
Speech intelligibility is defined as, “the match between the intention of the 
speaker and the response of the listener to the speech passaged through the 
transmission system” (Kent, 1992, pp. 13).  Speech intelligibility was rated by a group of 
15 adult, naïve independent listeners for all participants with ALS.  There are several 
ways to quantify speech intelligibility using naïve listeners.  The first procedure involves 
using a word identification task in which the listener writes down every word that the 
speaker says. The second procedure involves the use of a scaling protocol in which the 
listener makes judgments about the talker’s intelligibility using a technique such as an 
equal appearing interval scale or direct magnitude estimation (Kent, 1992).  Scaling 
procedures are an appropriate alternative to a more time-consuming, expensive, or 
cumbersome procedures, such as direct magnitude estimation and direct transcription. 
(Metz, Schiavetti, & Sitler, 1980).  A visual analogue scale (VAS) was used to measure 
speech intelligibility. The VAS scale consisted of a 10 cm line with anchors of 
“Completely Intelligible” and “Completely Unintelligible” (See Appendix B). The n=15 
naïve raters of participants’ speech samples were blinded to the objectives of the study 
and to the nature of the participants’ diagnosis.  They were, however, given the picture 
of the Cookie Theft description task before listening to the speech samples.  All naïve 
listeners were between the ages of 18 and 57 years, with no self-reported hearing 
problems.  Five listeners were graduate students in the School of Occupational Therapy 
at Western University.  Ten listeners were friends and relatives of KF.  All of the 
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listerners were naïve to the nature and purpose of the study.  They listened to the 
speech samples in a quiet environment with a sound pressure level of 70 decibels HL to 
ensure the samples were presented at a reasonable loudness level. The samples were 
audio samples only and did not portray any visual description of the participants.  The 
samples were given in three randomized orders.  Six participant samples were 
duplicated to access intra-rater reliability in judging speech intelligibility. This protocol 
was used successfully by Cooper et al., (2008) in her study of verbal naming among 
individuals with ALS. The inter-rater reliability score was strong for speech intelligibility 
across listeners (r = .850) using an interclass correlation coefficient.  The intra-rater 
reliability score also was strong (average r = .988) across all 15 raters using an 
interclass correlation coefficient. The purpose of accessing speech intelligibility in this 
study was to measure severity of dysarthria and to ensure any deficits found on 
category fluency tasks are attributable to language or cognitive-communication declines 
rather than to motor speech difficulties as a result of a possible mixed flaccid-spastic 
dysarthria. 
Data Analyses 
 Measures of central tendency were calculated including the mean, standard 
deviation, and range for all measures of language, speech intelligibility, cognition, 
depression, and quality of life. These values were calculated in order to compare scores 
to normative data and to describe overall trends in the data.    
Research question 1 addressed the association between language (BNT, verbal 
fluency (animals), total words, total utterances, MLU, CIU, CU, and Words/CU) and 
quality of communication (ASHA QCL), and the association between language (BNT, 
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verbal fluency (animals), total words, total utterances, MLU, CIU, CU, and Words/CU) 
and HRQoL (SF-36).  Pearson’s correlations were calculated between each measure of 
language and the ASHA QCL and SF-36.  In statistics, the Pearson product-moment 
correlation coefficient is a measure of the linear correlation (dependence) between two 
variables, giving a value between +1 and −1 inclusive. It is widely used in the social, 
cognitive, linguistic and neurosciences as a measure of the strength of linear 
dependence between two variables.  Given the normal distribution of the data in this 
study, Pearson’s correlations were chosen as the appropriate measure to analyze the 
relationship between the variables in the study.  The alpha level was set at p < 0.05 for 
all analyses.  However, a multiple comparisons correction was then applied to the 
significance level using a Bonferroni correction.  The Bonferroni correction was applied 
to each research question individually, as part of a “family wise correction error” in 
which each research questions was considered a “family comparison.”  The adjusted 
significance level for research question one was p < 0.003, to account for the sixteen 
correlations calculated in research question 1.  If the p values were less than 0.05 but 
did not meet the level of significance after the Bonferroni correction, they were 
considered to be approaching significance. 
Research question 2 addressed the association between speech intelligibility and 
quality of communication, and the association between speech intelligibility and HRQoL.  
A Pearson’s correlation was calculated between speech intelligibility and the ASHA 
QCL, and between speech intelligibility and the SF-36.  As described above, the alpha 
level was set at p < 0.05 and a multiple comparisons correction was then applied to the 
significance level using a Bonferroni correction.  The Bonferroni correction was applied 
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to the significance level for research question two separately, as part of a “family wise 
correction error” in which each research question was considered a “family 
comparison.”  The adjusted significance level for research question 2 was p < 0.025.   
Research question 3 addressed the association between speech intelligibility and 
each of the language measures (BNT, verbal fluency for animals, total words, total 
utterances, MLU, CIUs, CUs, and Words/CU).  Pearson’s correlations were calculated 
between speech intelligibility and each of the language measures scores.  As noted 
above, the alpha level was set at p < 0.05 and a multiple comparisons correction was 
applied to the significance level using a Bonferroni correction.  The Bonferroni 
correction was applied to each research question individually, as part of a “family wise 
correction error”, in which each research question was considered a “family 
comparison.”  The adjusted significance level for research question three was p < 0.006, 
to account for the eight correlations made in research question 3. 
Research question 4 addressed the relative contributions of the BNT, MoCA, 
GDS, speech intelligibility, and the ALSFRS-R to quality of communication (ASHA QCL) 
and to HRQoL (SF-36).  A hierarchical direct-entry regression analyses was performed.  
In hierarchical multiple regression, the predictor variables are entered in stages.  In the 
first stage, the predictor variables that we want to control for are entered into the 
regression. In the second stage, the predictor variables whose relationship we want to 
examine after the control variables are entered.  A statistical test of the change in R² 
from the first stage is used to evaluate the importance of the variables entered in the 
second stage.  The alpha level was set at p < 0.05.  The first stage of the model 
involved the BNT and the MoCA.  The second stage added the GDS.  The third stage of 
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the model added speech intelligibility.  In the last and fourth stage of the model, the 
ALSFRS-R was added.  After each model was computed, significance levels were 
reported to show to relative contributions and predictive power that each variable had 
when determining the criterion variable (ASHA QCL or SF-36).  Once all the variables 
were entered into each of the regression models, a regression equation for each 
criterion variable (ASHA QCL and SF-36) was calculated.  Zero-order, partial, and part 
correlations among all of the measures were reported.  Zero-order correlations are the 
direct correlations (Pearson’s correlations). A partial correlation coefficient is another 
way of expressing the unique relationship between the criterion variable (ASHA QCL or 
SF-36) and a predictor variable (BNT, MoCA, GDS, speech intelligibility, and ALSFRS-
R).  Partial correlations represent the correlation between the criterion variable and a 
predictor variable after common variance with other predictors has been removed from 
both the criterion variable and the predictor variable of interest. That is, after removing 
variance that the criterion variable and the predictor variable have in common with other 
predictors, the partial expresses the correlation between the residualized predictor and 
the residualized criterion variables. A part correlation coefficient represents the 
correlation between the criterion variable (ASHA QCL or SF-36) and a predictor variable 
(BNT, MoCA, GDS, speech intelligibility, and ALSFRS-R) that has been residualized 
with respect to all other predictor variables in the equation.  After removing variance that 
the predictor variable (BNT, MoCA, GDS, speech intelligibility, and ALSFRS-R) has in 
common with other predictor variables (ASHA QCL or SF-36), the partial expresses the 
correlation between the residualized predictor variable and the unaltered criterion 
variable. The square of the partial can be interpreted as the proportion of the criterion 
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variable (ASHA QCL or SF-36) variance associated uniquely with the predictor variable 
(BNT, MoCA, GDS, speech intelligibility, and ALSFRS-R).   
The purpose of these regression analyses was to analyze which predictor 
variables added significant predictive power to the regression equation when predicting 
each criterion variable (ASHA QCL or SF-36).  This means that the regression analysis 
was used to determine which scores on measures of language, cognition, depression, 
speech intelligibility, or disease severity are able to predict scores of quality of 
communication and HRQoL.  
Results 
The overall generalized results from the language measures, ASHA QCL 
measure and SF-36 measure are reported at the beginning of this section.  Each 
research question is then addressed individually thereafter.   
  The mean, standard deviation and range for each language measure and quality 
of communication life are presented in Table 2.  The mean, standard deviation and 
range of the SF-36 measure and each of its eight domains are presented in Table 3.  
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Table 2  
Language Measures and ASHA Quality of Communication Score (N=28) 
Language and HRQoL Scores Mean SD Range 
BNT (max 30) 25.25 3.63 15-30 
Verbal Fluency 95 19.88 65-142 
Animals 18.50 3.76 12-25 
Birds 12.85 3.00 9-20 
Water creatures 12.71 4.47 5-24 
Dogs 11.03 3.33 5-17 
Transportation 14.07 3.99 9-24 
Musical instruments 13.39 3.92 8-23 
Tools 12.42 4.34 5-21 
Cookie Theft description    
Total words 84.57 44.37 17-186 
Total utterances 11.39 4.96 5-28 
MLU 7.35 2.32 3.4-13.22 
Correct Information Units 56.18 28.07 23-123 
Content Units 10.17 3.23 2-17 
Words/Content Unit 8.83 4.62 3.5-15.54 
ASHA QCL  (max 85) 63.46 9.69 39-80 
Note. HRQoL = Health related quality of life, BNT = Boston Naming Test, MLU = Mean 
Length of Utterance, ASHA QCL = American Speech and Hearing Association’s Quality 
of Communication Life Scale 
Participants’ mean scores on the 30-item Boston Naming test were below normal 
values.  Normative data for the mean scores on the short form BNT for Caucasians 
aged 55 to 64 is 29.2 +/- 1.1 SD (Jefferson et al., 2007).  Nine participants’ scores on 
the BNT were between -1.5 to -2.5 SD below normals, and 14 participants were greater 
than -2.5 SD below normals.  Participants’ average verbal fluency scores for the 
category of animals also were below normal values.  Normative data for Canadians for 
the mean number of animals in the verbal fluency task for individuals 16 to 59 years of 
age with an education level of 13 to 21 years is 21.9 +/- 5.4 SD (Tombaugh, Kozak, & 
Rees, 1999).  Three individuals fell greater than -1.5 SD below the normal mean score 
of individuals similar to the average education of our participants.  Rakowicz and 
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Hodges (1998) reported mean scores for verbal fluency for all seven categories for ten 
participants with motor neuron disease but no aphasia or dementia (100.1 +/- 25.25 
SD).  Participants in our study performed somewhat more poorly on all categories of 
verbal fluency (95 +/- 19.88 SD) when compared to scores reported by Rakowicz and 
Hodges (1998).  
Table 3  
Healthy Related Quality of Life Scores on the SF-36 for ALS Participants (N=28) 
HRQoL Scores  Mean SD Range 
SF-36 Total Average Score 43.06 15.37 15-60.69 
Physical functioning 16.25 39.59 0-85 
Role limitations due to  
physical health problems 
 
32.14 
 
39.59 
 
0-100 
Role limitations due to 
emotional problems 
 
67.86 
 
35.70 
 
0-100 
Energy/fatigue 43.03 22.70 0-75 
Emotional well-being 78.14 14.58 28-92 
Social functioning 62.41 30.21 0-100 
Pain 63.84 29.61 0-100 
General health 42.5 19.41 5-80 
Note. HRQoL = Health related quality of life 
 Scores on the SF-36 are calibrated such that a score of 50 becomes the average 
score and the norm.  The overall mean score on the SF-36 for the n=28 participants in 
the study was below normal (see Table 3).  The most notably low average score was in 
the subdomain of physical functioning where as the highest average score was in the 
domain of emotional well-being, which was well above 50.  Mean subdomain scores 
that fell below 50 include the domains of physical functioning, role limitations due to 
physical functioning, energy/fatigue, and general health.  Mean subdomain scores that 
were above 50 include the domains of role limitations due to emotional problems, 
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emotional well-being, social functioning, and pain.  There was a high level of dispersion 
among the scores on the SF-36 and each of its subdomains.  Scores on four 
subdomains ranged from the lowest possible value of zero to the highest possible score 
of 100.   
Research Question 1 
Research question 1 addressed the association between the language measures 
and the quality of life measures. The association was examined to determine if an 
impairment of language performance in ALS affects the quality of communication or 
HRQoL among individuals with ALS.  Pearson’s correlation coefficients were computed 
between each language measure (i.e., BNT, verbal fluency for animals, total words, 
total utterances, MLU, CIU, CU, and Words/CU) and the ASHA QCL and SF-36 scores.  
The correlation coefficients and their p values are show in Table 4.  A moderate positive 
correlation was found between the ASHA QCL and language measures of verbal 
fluency (animals), total utterances, and words per content unit (p < 0.10), which 
approached the set significance level of p < 0.05. There were no significant correlations 
between any of the language measures and the SF-36.  A Bonferroni correction was 
applied to the significance level for each correlation that addressed research question 1 
to account for the multiple comparisons.  None of the language measures were 
significantly correlated after the correction was applied (i.e., p < 0.003).   
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Table 4 
Pearson’s Correlations Between Language and Quality of Life Measures (N=28) 
Language Measure ASHA QCL  p value SF-36 p value 
BNT -.198 .311  .119 .545 
Verbal Fluency  .480* .010  .063 .749 
Total Words  .230 .240 -.171 .385 
Total Utterances .354* .064 -.062 .754 
MLU -.030 .880 -.246 .207 
CIU  .122 .535 -.185 .347 
CU  .007 .971 -.186 .344 
Words/CU  .346* .071  .152 .440 
Note. *Correlation is significant at the 0.10 level (2-tailed).             
**Correlation is significant at the 0.05 level (2-tailed).                    
***Correlation is significant after Bonferroni correction.   
BNT = Boston Naming Test, MLU = Mean Length of Utterance, 
CIUs = Correct Information Units, CUs = Content Units 
 
Box plots were displayed using IBM Statistics SPSS Version 19 to determine if 
there were any outliers in the language and HRQoL data.  The box plots show the first 
quartile (bottom of box) and third quartile (top of box) (i.e., the 25th and 75th 
percentiles). The plots also display the median (the horizontal line in the box), the range 
(excluding outliers and extreme scores), the "whiskers" or lines that extend from the box 
show the range, and the outliers (a circle represents each outlier and the number next 
to the outlier is the participant number).  An outlier is defined as a score that is between 
1.5 and 3 box lengths away from the upper or lower edge of the box (the box represents 
the middle 50 percent of the scores).  An extreme score (represented by an asterisk) is 
defined as a score that is greater than 3 box lengths away from the upper or lower edge 
of the box.  Figure 1 shows that participants 6 and 22 were outliers and participant 28 
was an extreme value on the BNT data.  When these three participants’ BNT scores 
were excluded from analyses, the correlations between the BNT and the ASHA QCL (r 
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= -.243; p= .242) and between the BNT and the SF-36 remained not statistically 
significant (r = .190; p = .363).   
Figure 1 
Box Plots of the BNT Showing Outliers 
 
Participants 18 and 27 were the two outliers for Words/CU as shown in Figure 2.  
When these cases were excluded from analyses, the correlation between Words/CU 
and the ASHA QCL was r = 0.271 (p= .181).  The correlation between Words/CU and 
the SF-36 with the outliers excluded was r = -0.107 (p= 0.601), remaining not 
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statistically significant.  All of the variables for the language data were plotted using box 
plots and no other measures had any outliers or extreme scores. 
 
Figure 2 
Box Plot for Words per Content Unit Showing Outliers
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Research Question 2 
Research question 2 addressed the correlation between speech intelligibility and 
the quality of life measures. The correlation was calculated to determine if speech 
intelligibility is associated with quality of communication and HRQoL.  Table 5 shows the 
Pearson’s correlation coefficients and their associated p values.  Mean speech 
intelligibility scores ranged from 5.25 to 95.33.  There were no outliers when speech 
intelligibility scores were plotted using box plots.  
There was a moderately positive significant correlation between speech 
intelligibility and the ASHA QCL (see Table 5 below).  That is, as speech intelligibility 
declined scores on the ASHA QCL declined.  There was no significant correlation 
between speech intelligibility and the SF-36.  When the p value for research question 2 
was adjusted using a Bonferroni correction, the correlation between speech intelligibility 
and the ASHA QCL was still significant at the corrected p value (i.e., p < 0.025).  
Table 5  
Pearson’s Correlations Between Speech Intelligibility Measures and Quality of Life 
Measures (N=28) 
Quality of 
Communication 
Speech 
Intelligibility 
p value SF-36 p value 
ASHA QCL  .522*** .004 -.138 .483 
Note. *Correlation is significant at the 0.10 level (2-tailed).  
**Correlation is significant at the 0.05 level (2-tailed).  
***Correlation is significant after Bonferroni correction.   
ASHA QCL = American Speech and Hearing Association’s Quality of Communication 
Life Scale 
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Research Question 3 
 Research question 3 addressed the association between language performance 
and speech intelligibility. Table 6 shows the Pearson’s correlation coefficient between 
each language measure and the speech intelligibility score, and their associated p 
values.  There were positive significant correlations between verbal fluency (animals), 
total words, and total utterances with speech intelligibility.  Only the category of animals 
was used for the verbal fluency measure to minimize multiple comparisons.  Also, there 
are only normative data available for the verbal fluency category of animals.  There was 
a strong positive significant correlation between speech intelligibility and words per CU.  
That is, as speech intelligibility improved there was an increase in the number of words 
per content unit.  A Bonferroni correction was applied to the significance level to 
account for multiple comparisons.  When the Bonferroni correction was applied, none of 
the correlations reached significance (i.e., p < 0.006).  However, the correlation between 
speech intelligibility and words/CU approached significance. 
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Table 6  
Pearson’s Correlations Between Language and Speech Intelligibility Measures (N=28) 
Language Measure Speech Intelligibility p value 
BNT -.138 .485 
Verbal Fluency  .354* .065 
Total Words  .355* .064 
Total Utterances  .353* .065 
MLU  .102 .605 
CIU  .244 .212 
CU  -.159 .420 
Words/CU  .486** .009 
Note. *Correlation is significant at the 0.10 level (2-tailed). 
**Correlation is significant at the 0.05 level (2-tailed).  
***Correlation is significant after Bonferroni correction.   
BNT = Boston Naming Test, MLU = Mean Length of Utterance,   
CIU = Correct Information Units, CU = Content Units 
 
Research Question 4 
Regression Analyses 
Hierarchical direct-entry regression analyses were run by calculating a series of 
prediction equations to evaluate the relative contributions of cognitive or language 
impairments, depression, speech intelligibility, and physical function scores to ASHA 
QCL scores as a dependent variable.  The first stage of the model involved the BNT 
and the MoCA, yielding a non-significant prediction equation, F(2,24)= .3659, p = .527.  
The second stage of the model added depression (score on the GDS). Adding the 
depression score yielded a statistically significant effect for the predictive power of the 
combination of variables (F(1, 23)= 7.720, p = 0.011).  Speech intelligibility scores then 
were added to the analyses yielding a statistically significant effect (F(1,22)= 8.168, p = 
.009).  Finally, physical function (i.e., ALSFRS-R) was added to the analyses.  The ALS-
FRS values did not increase in the predictive power (F(1, 21) = .716, p = .407) beyond 
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that which was found when speech intelligibility was added to the equation The final 
analysis was statistically significant, F(5, 21) = 4.191, p = .008. Overall, the equation 
can be written as: 
ŷ= -.130 (MoCA) + .050 (BNT) -1.007(GDS) + .172 (Speech Intelligibility) - .147 
(ALSFRS)+ 74.883. The zero order, partial, and part correlations between each 
consecutive variable and the ASHA QCL are reported in Table 7. 
Table 7 
Zero-Order, Partial, and Part Correlations for MoCA, BNT, GDS, Speech Intelligibility, 
ALSFRS-R and the ASHA QCL 
Variable Zero-order  Partial  Part 
MoCA -.201 -.180 -.129 
BNT -.183  .024  .017 
GDS -.494 -.567 -.486 
Speech Intelligibility  .490  .537  .451 
ALS-FRS  .191 -.182 -.131 
Note. MoCA = Montreal Cognitive Assessment, BNT = Boston Naming 
Test, GDS = Geriatric Depression Scale, ALSFRS-R = ALS- Functional 
Rating Scale Revised 
The relative contributions of cognitive or language impairments, depression, 
speech intelligibility, and physical function to HRQoL were evaluated using a 
hierarchical direct-entry regression analysis. In this evaluation, a series of prediction 
equations were calculated with SF-36 as a dependent variable.  The first stage of the 
model included the BNT and the MOCA and resulted in a non-significant prediction 
equation, F(2,24)= .358, p = .703.  The second stage of the model added depression 
(scores on the GDS) which produced a statistically significant increase in the predictive 
power of the equation, F(1, 23)= 21.001, p < .001.  Speech intelligibility then was added 
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to the prediction equation, yielding no statistically significant change, F(1,22)= .698, p = 
.412.  Finally, physical function (ALSFRS-R) was added, which did not produce an 
incremental prediction beyond what was found when depression was added to the 
equation, F(1, 21) = .236, p = .632.  This final equation was statistically significant, F(5, 
21) = 4.433, p = .007, and can be written as:  ŷ= .036 (MoCA) + .908 (BNT) -2.234 
(GDS) -.090 (Speech Intelligibility) + .135 (ALSFRS-R) + 34.327. The zero order, partial, 
and part correlations between each consecutive variable and the SF-36 are reported in 
Table 8.   
Table 8 
Zero-order, Partial, and Part Correlations for MoCA, BNT, GDS, Speech Intelligibility, 
ALSFRS-R and the SF-36 
Variable Zero-order  Partial  Part 
MoCA  .162  .032  .022 
BNT  .116  .279  .203 
GDS -.655 -.690 -.665 
Speech Intelligibility -.132 -.203 -.145 
ALSFRS-R   .082  .105   .074 
Note. MoCA = Montreal Cognitive Assessment, BNT = 
Boston Naming Test, GDS = Geriatric Depression Scale, 
ALSFRS-R = ALS-Functional Rating Scale Revised 
Table 9 contains a summary of the significant research findings for the study. 
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Table 9. 
Summary of Significant Findings 
Research Question Significant Relationship 
RQ1a. Language measures and ASHA QCL Verbal Fluency* (r = .480) 
Total Utterances* (r = .354) 
Words/CU* (r = .346) 
RQ1b. Language measures and SF-36 NS 
RQ2a. Speech Intelligibility and ASHA QCL r = .522*** 
RQ2b. Speech Intelligibility and SF-36 NS 
RQ3. Language measures and Speech 
Intelligibility 
Verbal Fluency* (r = .354) 
Total Words* (r = .355) 
Total Utterances* (r = .353) 
Words/CU** (r = .486) 
RQ4a. Predictors of ASHA QCL GDS**, Speech Intelligibility** 
RQ4b. Predictors of SF-36 GDS**  
Note. *. Correlation is significant at the 0.10 level (2-tailed). 
**. Correlation is significant at the 0.05 level (2-tailed).  
***. Correlation is significant after Bonferroni correction.   
NS= not significant 
CU = Content Units 
 
Discussion 
 In this section, the meaning and importance of the overall findings are discussed 
first. These interpretations then are followed by a discussion of the significance and 
importance of the results for each research question. The section concludes with a 
discussion of the strengths and limitations of the study and possible future directions.   
Consistent with previous published literature (Abrahams et al., 2004; Abrahams, 
Leigh, & Goldstein, 2005; Mantovan et al., 2003; Racowicz & Hodges, 1998; South et 
al., 2011; Strong et al., 1999). the participants with ALS in this study exhibited word 
retrieval problems on the confrontation-naming task (BNT) as well as on the category 
fluency tasks (verbal fluency) Overall mean scores on the BNT were significantly below 
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normative data.  Although there are no normative data for six of the seven categories of 
verbal fluency used in this study, normative data for the category of animals suggests 
that a very small portion of the participants were slightly below normative values.  In 
comparison to total scores on the same seven of the categories of verbal fluency 
studied by Rakowicz and Hodges (1998), the participants with ALS in this study were 
below average on total number of exemplars compared to the ALS sample of their 
study.  These results are consistent with previous literature that shows that individuals 
with ALS without CI or FTD have language impairments such as word retrieval 
problems (Abrahams et al., 2004, 2005; Mantovan et al., 2003; Racowicz & Hodges, 
1998; South, et al., 2011; Strong et al., 1999), difficulties in both category and letter 
verbal fluency tasks (Abrahams et al., 2000; Hanagasi et al., 2002; Strong et al., 1999), 
and problems in confrontation naming (Abrahams et al., 2004; Hanagasi et al., 2004; 
Mantovan et al., 2003; Ringholz et al., 2005; Strong et al., 1999).  These findings mean 
this study adequately determined whether these language impairments, in the absence 
of CI or FTD, had the potential to affect participants’ quality of communication and 
HRQoL.  
 A cutoff score of 26 out of 30 on the MoCA indicates cognitive impairment 
(Nasreddine et al., 2005).  Ten participants with ALS in this study were unable to write 
and therefore could not complete the cube drawing and clock drawing portions of the 
MoCA.  MoCA scores for these ten participants were converted to percentages.  A 
value below 86.67% was considered a mild cognitive impairment.  Twelve of the 28 
participants exhibited a mild cognitive impairment using this threshold.  Such a finding is 
similar to previous ALS population-based studies that showed 47% of individuals with 
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ALS had no cognitive impairment whereas the remaining 53% showed some sort of 
cognitive impairment, including executive dysfunction (21%), non-executive dysfunction 
such as language or memory impairments (14%), comorbid FTD (14%), comorbid AD 
(2%), and others with limited categorization (2%) (Phukan et al., 2012).  A cognitive 
impairment (CI) in the absence of FTD also is common in individuals with ALS.  
Although participants with ALS and CI were not excluded from this study, a mild 
cognitive impairment (MCI) can contribute to poorer performances on tests of language.  
For example, studies show that persons with MCI exhibit language deficits including 
verbal fluency, especially category fluency, confrontation naming, as well as language 
comprehension (Ritchie, Artero, & Touchon, 2001), accuracy in syntactic reasoning 
(Collie, Maruff, & Currie, 2002), and naming a rhyming word (Dwolatzky et al., 2003). 
Alterations in performance on a variety of other semantic tests also have been reported.  
For example, problems with lexical decision making, (Taler & Jarema, 2006), semantic 
categorization (Olichney et al., 2002), semantic encoding (Puregger, Wala, Deecke, & 
Dal-Bianco, 2003), and semantic priming (Davie et al., 2004) have been reported in 
MCI.  A MCI also could affect participants’ abilities to answer the quality of 
communication and HRQoL measures. For example, those with MCI exhibit problems 
with episodic memory (Backman, Small, & Fratiglioni, 2001), executive function (Albert, 
Moss, Tanzi, & Jones, 2001), perceptual speed (Albert et al., 2001), verbal ability 
(Convit et al., 2000), visuospatial skills (Albert et al., 2001), and attention (Nielson, Lolk, 
Anderson, Anderson, & Kragh-Sorenson, 1999).  All of these potential impairments 
could affect the abilities of participants in this study to understand the task, to read the 
task correctly and to make inferences about themselves while completing the self-rated 
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scales used to assess quality of communication and HRQoL.  Impairments to cognitive-
communication also could affect quality of communication and HRQoL scores.  For 
example, it may not strictly be a language impairment that affects participant’s everyday 
communication but an overall cognitive impairment that affects their ability to have 
meaningful communication.  Taylor et al. (2012) found that executive dysfunction and 
language dysfunction commonly occur together in ALS. However, separate impairments 
in either executive dysfunction or in language can exist in ALS.  This means that 
executive dysfunction in the absence of a language impairment could also affect 
communication.  Cognitive issues in ALS, are part of an under recognized feature of 
ALS, and should assessed by clinicians, because they are prominent (e.g., 35%-50%) 
in the ALS population at large.   
 Previous literature suggests that approximately 10% of individuals with ALS are 
clinically depressed (Kurt et al., 2007, McElhiney et al., 2012, Tremblay, Monchi, 
Hudon, Macoir, & Monetta, 2012) Findings of depression among the participants with 
ALS in this study showed a slightly higher rate of depression using the GDS.  Seven 
participants with ALS were categorized as moderately depressed (score of 10 to 19). 
One participant showed a severe depression (score of 22/30).  A second participant 
was unable to complete the GDS because of a severe evoked emotional response 
relative to the nature of the questions in the GDS.  McElhiney et al. (2012) reported that 
depression in ALS was not associated with disease severity, and prevalence rates of 
depression do not increase as disease duration increases.  It is likely then that those 
individuals who exhibited mild depression would continue to have these depressive 
symptoms had they been followed over time.  Because depression has been shown to 
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affect cognition (Lichetenburg et al., 1995), the high occurrence of mild to severe 
depression in this study could be associated with the high occurrence of mild cognitive 
impairment (as reported by the GDS and MoCA scores, respectively).  It is important for 
individuals with ALS and for their attending physicians, to be aware of, to report and to 
treat depressive symptoms, because depression can greatly affect cognition, 
communication, and HRQoL.   
 The SF-36 is a norm-based measure of health related quality of life. It has a 
normal score of 50. Twenty of the 28 participants with ALS in this study fell below that 
threshold value, indicating an overall poorer HRQoL than the normal population.  Most 
notably, low scores occurred in the domains of physical functioning, role limitations due 
to physical functioning, energy/fatigue, and general health.  This is not unexpected due 
to the clinically significant physical problems associated ALS.  Similar to findings from 
previous studies (i.e., scores on the ALSFRS-R, Tramonti et al., 2012), the scores of the 
study participants in the domain of physical functioning on the SF-36 were low.  The 
highest average score was in the emotional wellbeing domain of the SF-36, meaning 
that although many individuals rate their physical functioning as low, they still rate their 
emotional wellbeing generally much higher.  Mean scores in the subdomains of role 
limitations due to emotional wellbeing, social participation, and pain were all above 
normal. The importance and significance of these results is that they replicate findings 
in the published literature that shows physical functioning is not the main determinant of 
overall HRQoL in ALS (Chio et al., 2004; Lulé et al.,, 2008; Nygren & Askmark, 2006; 
Robbins et al., 2001). More importantly, the findings of this study show that other factors 
affect HRQoL, such communication impairments and social relationships. The 
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significance of the finding that communication relates to HRQoL in ALS is that 
communication should be optimized in order to optimize HRQoL in ALS. 
 The ASHA QCL scores were quite variable among the study participants with 
ALS. Several study participants exhibited a high self-rated quality of communication 
whereas others rated their quality of communication quite low.  Although no normative 
data are available on the ASHA QCL to compare participants’ scores to that of a larger 
normal population, overall scores on the ASHA QCL are quite low, indicating a poor 
quality of communication in participants with ALS.  This finding is important in that is 
shows that both speech and language impairments are contributing to the overall low 
quality of communication scores, given the wide range of speech intelligibility and 
language scores across participants.  Participants did complete question 18 of the 
ASHA QCL, which asked them to rate their overall QoL on a 5-point likert scale.  
However, there was no relationship between question 18 on the ASHA QCL and the 
ALSFRS-R. This means that when participants with ALS gave a global rating of their 
overall QoL, it was not associated with their level of physical functioning.  This finding is 
significant because it indicates that other factors, such as communication and social 
relationships, are contributing to overall QoL.  
 Although the ALSFRS-R is a psychometrically sound tool to determine physical 
functional capacity and survival times in ALS, there are no published scores that are 
considered normal in the widely variable and individualized progression of ALS 
(Castrillo-Viguera, Grasso, Simpson, Shefner, & Cudkowicz, 2010).  It is important to 
distinguish that length of disease duration in ALS does not indicate disease severity.  
Although the length of disease duration for each participant in this study was not 
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reported, the severity of disease, as determined by the ALSFRS-R, was reported.  Many 
of the participants in the current study were highly functional with high scores (as 
established by scores of 40 or more) on the ALSFRS-R (score of 45/48), whereas 
others were extremely low (score of 13/48).   
 Overall, the preliminary results are in keeping with previous published studies in 
ALS as reported above.  The study sample was representative of the ALS population at 
large in terms of prevalence of language impairments, depression, and MCI.  The 
physical limitations represented in the sample also are similar to the general ALS 
population, which varies greatly in the site of onset, symptoms of disease, severity of 
disease, and disease duration.  The study sample is a meaningful group to address the 
proposed research questions.  
Research Question 1 
 Research question 1 addressed the associations between language and quality 
of communication, and between language and HRQoL.  The question was posed to 
determine if an impairment of language performance in participants with ALS affects 
their quality of communication or their HRQoL.   
Scores on the BNT did not correlate significantly with scores on the ASHA QCL.  
However, other measures used in this study to access language performance correlated 
moderately well with the ASHA QCL and, in some instances, approached significance.  
Verbal fluency for the category of animals, as well as total utterances and words per 
content unit on the Cookie Theft description task (BDAE), showed a moderate 
correlation that approached significance.  This means that, although many individuals 
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with ALS have difficulty on confrontation naming tasks (Abrahams et al., 2004; 
Hanagasi et al., 2004; Mantovan et al., 2003; Ringholz et al., 2005; Strong et al., 1999), 
as was the case among the participants in this study, these difficulties may not be 
associated with participants’ self-rated quality of communication.  This also could be 
explained by the questions addressed in the ASHA QCL, which do not include 
questions about language or cognitive performance but which focus more on 
communication participation, social engagement, and speech intelligibility.  Moreover, 
individuals with ALS may not be aware that language and cognitive problems occur in 
ALS.  Language deficits in ALS have been under recognized for many reasons.  
Prominent dysarthria provides a plausible explanation for abnormalities in language 
production.  Simple picture naming tasks, such as that of the BNT, are not 
representative of deficits beyond the single word level.  Many of the tasks used to 
assess language and cognition in this study were developed to be used on persons with 
intact motor functions, meaning that physical functioning also could have affected 
participants’ performance on many of the tasks, although this is only a remote possibility 
given the nature of the assessment tasks. 
The word generation task (i.e., verbal fluency task for animals) was mildly 
correlated to the ASHA QCL, meaning that the more words the participant was able to 
generate, the better the participant rated their quality of communication.  It is well 
documented that individuals with ALS also are impaired in letter fluency tasks 
(Abrahams et al., 2004), which should be addressed in future studies of executive 
functioning and HRQoL.  Interestingly, there was a positive correlation between words 
per content unit and the ASHA QCL.  Words per content unit is considered a measure 
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of content efficiency in discourse tasks.  The more words per content unit, the less 
efficient participants were in describing the picture. This means that they used more 
words to convey the content of the picture.  Total utterances, which also was correlated 
positively with the ASHA QCL, is a measure of productivity in discourse.  These results 
suggest that individuals who are using more words and more utterances per content 
unit are rating themselves higher on the ASHA QCL.  Overall, measures of content 
efficiency and content productivity in discourse samples are associated with quality of 
communication whereas measures of content were not associated with quality of 
communication. This could be due to their severity of dysarthria, which limits their 
speech output.  This theme is addressed in the discussion of findings for research 
questions 2 and 3. The results for research question1 suggest that reduced content 
efficiency during discourse could affect overall quality of communication.  Although 
many individuals preformed poorly on confrontation and generative naming tasks, it was 
mainly the efficiency in discourse measures that were correlated to quality of 
communication.  The significance of these findings is that discourse performance is 
more important to the quality of communication for individuals with ALS than is their 
ability to recall the names of nouns in a confrontation task or on category retrieval task 
(i.e., verbal fluency).  Discourse can be conceptualized as “representing that level of 
communicative function wherein the interaction between linguistic and cognitive abilities 
is most clearly manifested, and where complexity of language is quite high” (Ulatowska, 
Cannito, Hayashi, & Fleming, 1985, p. 128).  The challenge of complexity of discourse 
tasks in individuals with ALS could be the reason for why the association with quality of 
communication is so high.  More complex tasks, such as the discourse task used in this 
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study may be more representative of communicative dysfunction in ALS versus that of 
simple word recognition and word generation. It appears that deficits at the single word 
level may not translate into important communication difficulties in individuals with ALS.  
Further research into discourse performance in ALS and its association with quality of 
communication should be examined, because our study showed that efficiency and 
productivity measures of discourse are correlated with quality of communication.  The 
strategies individuals with ALS are using during discourse, as well as the relationship 
between discourse output and speech intelligibility, need to be examined further.  The 
prominent dysarthria in some individuals with ALS offers a plausible explanation for 
poor discourse performance. Future research into the relationships between speech 
intelligibility and discourse performance are warranted.   
 There was no association between language performance and overall HRQoL 
(SF-36).  It is not surprising that there was no statistically significant association given 
that the SF-36 is heavily weighted in the physical domain and does not address 
questions about communication.  Because language performance was correlated with 
quality of communication life scores, language could indirectly affect HRQoL but not 
through measures that are primarily focused on physical issues.  Also, because a 
HRQoL measure was used versus using a general QoL measure, future studies that 
include QoL measures could reveal an association with language performance among 
individuals with ALS. 
Research Question 2 
 Research question 2 examined whether there is an association between speech 
intelligibility and quality of communication (ASHA QCL), and between speech 
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intelligibility and HRQoL (SF-36) in individuals with ALS. Findings showed that there is a 
moderate statistically significant positive correlation between speech intelligibility and 
the ASHA QCL.  This finding is not entirely surprising given that there are multiple 
questions on the ASHA QCL that address speech intelligibility issues relative to quality 
of communication.  Speech intelligibility was not associated with the SF-36, which again 
could be due to the physical focus of the items on the SF-36 relative to health related 
quality of life.  For example, an individual with limb onset ALS could have very low 
scores on the SF-36 due to their physical immobility issues but simultaneously could 
have high speech intelligibility because their speech muscles are not as affected by the 
disease.  Because speech intelligibility is moderately associated with quality of 
communication, it would be expected that speech intelligibility would alter global ratings 
of QoL. Further research is warranted to explore the relationship between speech 
intelligibility and its contributions to quality of communication and HRQoL.  Alternative 
methods in analyzing speech intelligibility in ALS may provide further insights into the 
relationship between speech intelligibility and quality of communication.  For example, a 
direct transcription method of assessing speech intelligibility could lower scores of 
perceived speech intelligibility and could be more highly correlated with scores of quality 
of communication. 
In order to improve communication quality of life among individuals with ALS, 
future research should focus on speech intelligibility issues and managing symptoms of 
dysarthria in individuals with ALS.  Clinically, the typical main focus of speech-language 
pathologists (SLP) who treat in individuals with ALS is on their speech and swallowing 
concerns (Bedlack & Mitsumoto, 2012).  Based on the findings from this study, SLP 
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should continue to focus on helping individuals use strategies to maintain spoken 
communication (i.e., discourse output beyond the single word), including voice 
amplification devices and other AAC devices to optimize speech intelligibility and 
therefore improve quality of communication life.  
Research Question 3 
 Research question 3 addressed whether there is an association between 
language performance and speech intelligibility in individuals with ALS.  An emerging 
association (i.e., approaching statistical significance) was found between language 
performance on verbal fluency for animals, total words, and utterances on the Cookie 
Theft picture description task and speech intelligibility. This is an important finding, 
because it means that performances on these language tasks could have been affected 
by participants’ motor speech impairments.  More importantly, there was a moderate but 
significant positive correlation between speech intelligibility and words per content unit 
on the Cookie Theft picture description task.  These results suggest that those 
individuals with ALS who have poor speech intelligibility are likely to exhibit reduced 
verbal output and reduced content productivity on a picture descriptions task.  Picture 
description tasks often are used to elicit a language sample of adults with speech, 
language and cognitive-communication disorders. Based on this finding, it is important 
for SLP to optimize speech intelligibility as well as language and cognitive performances 
in order to optimize discourse production. Individuals with ALS and its associated mixed 
dysarthria are likely to say few words overall and to use few content words to convey 
information (i.e., few content units). These individuals could be using strategies to limit 
the number of words they use to convey information, such as leaving out propositions 
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and conjunctions (Hammen & Yorkston, 1996).  Based on the findings for research 
question 3, SLP, must focus on optimizing speech intelligibility in individuals with ALS 
while being conscious of the effects of speech intelligibility on language and discourse 
productions measures. Future studies should explore this possibility among individuals 
with moderate to severe dysarthria associated with ALS. Moreover, future studies could 
explore this relationship via written modalities to parcel out the effects of poor motor 
speech performance. 
Research Question 4 
 Research question 4 addressed the relative contributions of the BNT, MoCA, 
GDS, speech intelligibility, and the ALSFRS-R on the quality of communication (ASHA 
QCL) and on a general measure of HRQoL (i.e., SF-36).  The purpose of research 
question 4 was to determine which variables were able to predict scores on the ASHA 
QCL and SF-36.  In the hierarchical direct-entry regression model used to predict the 
ASHA QCL scores, speech intelligibility added the most predictive power to the 
prediction equation.  This means that speech intelligibility has a significant influence on 
how individuals with ALS rate their quality of communication.  This finding was expected 
due to the number of questions on the ASHA QCL that address issues related to 
speech intelligibility.  The GDS also added significantly to the equation, indicating that 
depression may be a factor in quality of communication among individuals with ALS. 
Many of the 18 items in the ASHA QCL, however, contain items related to social 
participation (e.g., I like to talk with people, I get out of the house and do things like 
dinners, parties, and shows, etc.).  Social participation is affected by depression (Kivela, 
1994). Consequently, the presence of depression among individuals with ALS will yield 
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lower scores on the ASHA QCL.  Given that there were seven participants in the study 
with mild depression, as measured by scores on the GDS, it is not surprising that 
depression loaded onto the regression equation that predicted HRQoL. It was 
established at the outset of the study that we would not use depression as an exclusion 
criteria, because many individuals would have scores indicating the presence based on 
the nature of their disease and the literature in ALS noting the prevalence of depression 
(Kurt et al.,, 2007; McElhiney et al., 2012).  Depression was used instead as a predictor 
variable to determine its contributions to quality of communication and HRQoL.  
Physical functioning in ALS, measured by items on the ALSFRS-R, was not a 
significant contribution to the AHSA QCL equation. This lack of effect on the quality of 
communication was not surprising, because the ASHA QCL does not contain items that 
address physical functioning. Although the cognitive and language scores did not 
contribute the most to the regression equation, it is most interesting that the MoCA, 
BNT, GDS, and speech intelligibility scores can explain 40% of the variance in the data.  
The importance of this finding is that quality of communication is not determined by one 
factor alone.  Many factors, such as cognition, language performance, dysarthria and 
fatigue, can affect communication in ALS.  Quality of communication in ALS is complex, 
with many different factors playing a role including, overall cognitive performance, 
naming, mood/emotional valence, and speech clarity. 
 In the hierarchical direct-entry regression model used for the SF-36, the only 
variable that added a significant predictive power to the equation was the GDS.  This 
means that individuals with ALS who experience depression could have greatly lowered 
HRQoL.  Goldstein et al. (2002) showed that depression was not significantly correlated 
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with overall QoL (SEIQoL-DW scores).  Interestingly, the ALSFRS-R scores did not add 
any incremental increase to the significance of the equation, indicating that physical 
functioning is not associated with overall health related quality of life.  This is interesting 
considering the physical nature of the SF-36 and the low scores that were shown in the 
physical domains of the SF-36 by study participants.  These results are in contrast to 
previous studies by Robbins et al. (2001), in which the authors used the ALS-specific 
HRQoL scale (SIP/ALS-19) to measure HRQoL in ALS. The SIP/ALS-19 contains items 
that are primarily based on physical function. Robbin et al. (2001) found that SIP/ALS-
19 scores decline in parallel with scores on the ALSFRS-R.  Tramonti et al. (2012) also 
found an overlap in the domain of physical functioning when comparing scores on the 
physical functioning subscale of the SF-36 and the ALSFRS-R. Based on the findings 
from this study, individuals with ALS, their family members, their caregivers, and their 
medical and health care clinicians should be aware of the profound impacts that 
depression can have in ALS.  The findings from this study show that almost 45% of the 
variance (adjusted R square) can be explained by scores from the BNT, the MoCA, and 
the GDS when predicting the SF-36. This finding shows the overall significance that 
cognition, language, and depression have on HRQoL in individuals with ALS. Clinicians 
should be prepared to acknowledge depressive symptoms in individuals with ALS, 
which can affect HRQoL more than physical symptoms alone. 
Strengths and Limitations 
Participants. One strength of the study was that the n=28 participants recruited 
were a representative sample of the ALS population at large, as the demographics of 
the sample compares favourably with larger, epidemiological studies of persons with 
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ALS (Beghi et al., 2006; Phukan et al., 2012).  For those participants with ALS who 
were interested in participating but were no longer attending University Hospital due to 
fatigue and accessibility issues, the study was completed in their homes.  Some 
individuals with ALS who declined to participate did so because of significantly impaired 
speech intelligibility (n=2), whereas others who were anarthric were not contacted (n=3).  
This is a limitation of the study, because the sample might be considered biased 
towards individuals who had less severe dysarthria than the ALS population at large.  
Participants who had PCO2 levels greater than 70 mmHg also were excluded, which 
could have excluded individuals who had respiration issues or respiratory onset ALS.  
This means that the sample could be biased towards those who were not experiencing 
severe bulbar and respiratory limitations. However, the respiratory threshold criteria 
eliminated those persons with ALS who could likely suffer cognitive impairment as a 
result of respiratory insufficiency (Kim et al., 2007). 
 Participant 3 had a GDS score of 22 out of a possible 30, indicating severe 
depression. Seven other participants scored between 10 to 19 out of 30 indicating mild 
depression.  One participant was unable to complete the GDS because of a severe 
emotional reaction to the testing.  The prevalence of depression in this study was 
slightly higher than the prevalence of depression in the ALS population at large (Kurt et 
al., 2007; McElhiney et al., 2012), meaning that depression in this study could be 
affecting cognitive status.  This is a limitation because the prevalence of depression in 
this study could account for low cognitive performance, low self-rated quality of 
communication, and low HRQoL scores. 
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 Ten participants were unable to write and therefore were unable to complete the 
cube drawing and clock drawing portion of the MoCA.  Their trail-making subtest on the 
MoCA was completed verbally (i.e., they described the sequence of connecting the 
letters and numbers). The MoCA scores for these participants were scored out of 26 
and all scores were converted to a percentage score.  The individuals who were unable 
to complete these parts of the MoCA could have an overestimation of cognitive 
performance.  A score greater than or equal to 26 on the MoCA is considered normal.  
Even when correcting for those scored out of 26, twelve participants fell below normal 
(<86.66 %) indicating mild cognitive impairment in some individuals.  Three individuals 
fell below a 70% score on the MoCA, indicating a somewhat severe cognitive 
impairment.  The presence of cognitive impairment in many of the participants could 
have hindered their ability to answer questionnaires such as the SF-36 and ASHA QCL, 
which requires language skills, attention, and self monitoring, among other cognitive 
abilities to complete. 
Procedure. One weakness of the procedure used in the study was the timing 
during the day when testing took place.  A few participants completed the study during 
late afternoon sessions after already completing a full clinic visit in the Motor Neuron 
Disease Clinic.  This is a limitation because these participants may have been mentally 
and physically fatigued, which could have affected their performance on many of the 
cognitive and language tasks. However, all participants but one agreed to complete the 
data collection after being asked if they wanted to postpone to another time period.  
Overall, the procedure was carried out in a consistent order, in a timely manner (1 to 1.5 
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hours) and in a comfortable environment to minimize the effects of fatigue. Rest periods 
were offered to all participants. 
The duration of disease onset and site of disease onset were not reported in this 
study, which proved to be a limitation.  Further analysis using these two factors could 
have shown some interesting results.  For example, those individuals who have had 
time to come to terms with their prognosis may have had lower scores of depression 
and conversely, those individuals who have been living with the disease for longer may 
have poorer HRQoL.  Because these data were not collected, speculations about 
possible relationships among time post onset, disease severity, and HRQoL cannot be 
made at this time.  Also, speech intelligibility, a bulbar feature of the disease, was 
assessed. This does not necessarily mean these individuals had bulbar onset ALS.  
Also, those individuals who did not experience bulbar symptoms but had low respiratory 
support could also have had poor speech intelligibility due to volume issues.  Future 
studies separating participants into groups based on time post onset, severity, site and 
type of disease onset (upper vs lower limb; bulbar vs. nonbulbar) may provide useful 
results, as ALS is such a variable disease in its onset and progression.  Perhaps 
individuals with different sites of disease onset may have differing views on quality of 
communication and HRQoL.  For example, an individual who has lost the physical 
ability to speak may place more importance on speech intelligibility when rating their 
quality of communication, whereas an individual who has no signs of dysarthria may 
place a greater importance on word findings difficulties when rating their quality of 
communication.  Moreover, individuals with limb onset ALS could rate their HRQoL on 
  64 
the SF-36 as lower due to its number of questions regarding walking, climbing, lifting, 
bending, etc.  Future studies should take all of these considerations into account. 
Materials and Methods. The ASHA QCL does not contain questions that 
specifically address language and cognitive problems relative to communication 
problems.  All questions address speech issues and communication-related 
participation issues (e.g. “I get out of the house and do things such as movies, dinners, 
and shows” or “I like talking with people”).  It is not surprising that many of the language 
measures did not significantly correlate to the ASHA QCL, because they are not 
conceptually linked in any way.  Although an emphasis was placed on the 
communication context of the test before administration, it is likely that many 
participants took into account their physical limitations when answering specific 
questions such as, “I meet the communication needs of my job or school,” “I get out of 
the house and do things,” or “I have household responsibilities.”  Future development of 
a quality of communication life questionnaire, that incorporates all aspects of 
communication (i.e., speech, voice, resonance, articulation, language, cognition, etc.) 
that are affected in individuals with ALS would be prudent. 
 The HRQoL measure (i.e., SF-36) is weighted heavily with physical domain 
questions (e.g., “Does your health limit activities such as vigorous activities, moderate 
activities, lifting or carrying groceries, climbing stairs, etc.?”).  Although it is an excellent 
tool to access health related quality of life, the study did not include a tool to reflect 
overall QoL.  A tool that accessed domains such as spiritual factors, socioeconomic 
factors, and social support, which have been shown to be important factors in QoL for 
individuals with ALS (Murphy, Albert, Weber, Del Bene, & Rowland, 2000; Simmons et 
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al., 2000), may have been more appropriate.  Many participants with ALS reported that 
they were unsure about how to define the term “sick” while completing the 
questionnaire.  Although those participants who asked were told to define “sick” in any 
way in which they felt the term was significant to them, some considered their disease a 
sickness while others considered sickness within the same context as a cold or a flu 
type illness.  Although previous studies indicated that there was no relationship between 
overall QoL and disease duration or site onset, HRQoL may have been related to 
disease duration and site of onset, which was not captured in this study.  
Data Analyses. Pearson’s correlation coefficients make two assumptions. The 
first assumption is that the variables are bivariately normally distributed. The second 
assumption is that the cases represent a random sample from the population and the 
scores on these variables for one case are independent of scores on these variables for 
other cases (Salkind, 2011).  The participants of the study do not represent a random 
sample of the ALS population (i.e., they are a convenience sample).  However, scores 
on each of the measures are independent of one another, Pearson’s correlations were 
an appropriate statistical measure to analyze the relationships among variables.  
However, because each research question had multiple comparisons, Bonferroni 
corrections were applied to the significance level for each research question.  The alpha 
level for each research question was significantly lowered using the correction and thus, 
may have been too restrictive. 
 The regression model used in the data analysis included five predictor variables.  
A rule of thumb to consider when doing regression analysis is to include ten participants 
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per independent variable in the regression model.  Thus, the regression model used in 
this study was not heavily powered by the sample size. 
Future Directions 
Research. It may be the case that individuals living with ALS and their caregivers 
are naïve to the fact that language and cognitive issues exist in ALS.  The relatively 
recent discovery that language and cognitive impairments do occur in ALS may not be 
well known among persons with ALS or their caregivers. Future studies should explore 
whether individuals with ALS and their family caregivers are aware of the potential 
language and cognitive deficits in ALS, whether they are experiencing any language or 
cognitive deficits throughout their disease progression, and what associations, if any, 
exist between language and cognition and HRQoL.  Future analyses also should 
address the determinants of caregivers of individuals with ALS HRQoL, which has been 
shown to decrease as their loved ones physical functioning decreases (Roach et al., 
2009).  It is known that the presence of neurobehavioural symptoms associated with 
ALS-FTD correlates significantly with lower caregivers’ QoL, higher caregiver 
depression, and higher caregiver burden (Chio et al., 2010). These correlations can 
have profound impacts on caregivers’ emotional status (Chio, et al., 2010).  However, 
the effects that language impairments in individuals with ALS without ALS-FTD has on 
caregivers’ HRQoL remains to be explored. Future study of the determinants of HRQoL 
in indivuduals who are caregivers of persons with ALS is warranted. 
Further analysis into the relationship between dysarthria and discourse should be 
examined in ALS as well.  Dysarthria could be masking potential affects of language 
impairments in ALS, and the relationship between these two parameters needs to be 
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addressed fully.  A study, that examines the discourse sample of individuals with ALS 
without CI versus other progressive degenerative neurological diseases that affect 
speech intelligibility without any language or cognitive deficits would provide insight into 
the strategies individuals with dysarthria use during discourse.  Also, a more 
comprehensive analysis of the discourse samples in this study is warranted, (e.g. 
examining revisions, reformulations, and self-corrected utterances in the discourse 
samples which have been shown to be decreased in ALS).   
The MoCA may not be an adequate tool to screen cognition in ALS because of its 
physical requirements.  The cognitive status of individuals with ALS who are unable to 
complete the cube drawing and clock drawing proportion of the MoCA might yield 
scores that underestimate the severity of their cognitive impairments.  The development 
of a cognitive screening tool that is specific to ALS is a necessity for future studies of 
cognition in ALS. Work by Abrahams, and colleagues and by Bak and colleagues 
showcased at the recent 4th International Research Workshop on ALS held in London 
ON (June 2013) indicates that screening measures soon will be published.  
A quality of life scale that is specific to ALS has been developed, called the 
ALSAQ-40 (Jenkinson et al.,1999). This scale does not include questions that address 
aspects of communication, including language or cognitive-communication difficulties.  
Future scales used to assess quality of life in ALS need to include questions about 
communication, and less emphasis should be given to the physical domain of quality of 
life.   
Currently, the quality of communication life scales available to researchers and 
clinicians do not address all aspects of the communication difficulties experienced by 
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individuals with ALS.  The ASHA QCL used in this study did address an individual’s 
ability to participate in social communication but neglects participants’ abilities to use 
language effectively.  Questions related to the quality of communication should be 
included in future QoL measures, including speech difficulties in ALS and discourse 
performance (e.g., efficiency and productivity measures). There is a definite need to 
develop quality of communication measures that include items related to word finding 
difficulties and discourse production. 
This study used a cross sectional design.  Future longitudinal studies are needed 
to address the changes of quality in communication and HRQoL over the progression of 
the disease.   To assess changes over time, alternate versions of the language test that 
are psychometrically equivalent but have different content will be needed to ensure 
there is no learning affect across the testing periods.  The quality of communication 
scale and HRQoL scale also must be sensitive to change.  It is prudent to measure the 
changes in quality of communication and HRQoL, because ALS is such a rapidly 
progressing disease. 
 Clinical. Difficulties with speech and swallowing occur commonly in individuals 
with ALS and often are the primary focus of care by SLP. However, language and 
cognitive communication issues also need to be a concern for SLP when assessing and 
treating individuals with ALS, especially within the context of health related quality of 
life.  Moreover, SLP need to be concerned with the presence and effects of depression 
on communication related quality of life, since results from this study showed that 
depression can predict both poor quality of communication and HRQoL. SLP need to be 
aware of not only the physical limitations the disease places on individuals but also how 
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depression and cognition impairments may affect communication related quality of life 
of individuals with ALS and, potentially, of their caregivers.  Counseling individuals with 
ALS, and their family members with respect to declines in all aspects of communication 
and offering supportive speech, language, and communication strategies and coping 
skills relative to HRQoL may prove to be very beneficial.  
Summary and Conclusions 
The results from this study indicate that individuals with ALS exhibit language and 
cognitive impairments as well as speech intelligibility issues that affect their quality of 
communication and HRQoL. Physical functioning is not a main determinant of HRQoL in 
ALS.  Depression was the main predictor for low HRQoL.  Futhermore, speech 
intelligibility is highly associated with quality of communication.  Further studies should 
include a larger sample size, a more extensive battery of tests used to assess 
language, as well as a more detailed analysis of the relationship between discourse in 
ALS and HRQoL.  These studies should also use more well-developed tests of quality 
of communication, screens of cognition, and HRQoL that are specific to ALS and more 
appropriate for the ALS population. 
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Study Title: “Language Contributions to Amyotrophic Lateral Sclerosis” 
 
Study Investigators:  
J.B. Orange, PhD 
Professor and Director 
School of Communication Sciences and Disorders 
Western University 
 
Katie M. Findlater 
Masters Candidate, Health and Rehabilitation Sciences 
Speech and Language Science Field 
Western University 
 
Christen Shoesmith 
MD, FRCPC, Neurologist 
Clinical Neurosciences 
London Health Sciences Center, University Hospital 
 
 As a person diagnosed with amyotrophic lateral sclerosis (ALS), you are being 
invited to take part in a research study conducted through Western University to 
develop of a better understanding of the relationship between language and cognitive-
communication deficits and health related quality of life in amyotrophic lateral sclerosis.  
The purpose of this letter is to provide you with information required for you to make an 
informed decision regarding participation in this research. Our study will include twenty-
eight participants who also attend the Motor Neuron Disease Clinic at London Health 
Sciences Centre with ALS.  It is important for you to be aware of why this study is being 
conducted and what it will involve.  Please take the time to read this letter carefully.  
Please feel free to ask any questions if any part of the explanation of our study is 
unclear.  
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 If you agree to participate in our study, data will be collected at London Health 
Sciences Centre, University Hospital, in London, Ontario.  You will be compensated $20 
for parking expenses, light refreshments, and for your participation. 
You will be asked to complete a short hearing test to see how well you can hear 
in both ears. This task will take approximately 5 minutes.   Then you will be asked to 
complete tasks to assess your thinking and your communicating skills. The tasks are 
designed to assess your thinking; that is your ability to plan, to organize, to concentrate, 
to make decisions, and to use and to understand language, etc.). In total, these tasks 
will take approximately 90 to 120 minutes.  You will be asked to complete these tasks 
using a pen and paper.  In the first task, you will be asked to complete 30 Yes-No 
questions regarding your mood and assess how happy or depressed you feel.  This will 
take approximately 20 minutes to complete. Then you will be asked to name thirty black 
and white drawings of objects. This task will take approximately 20 minutes. Next you 
will be given a category (e.g. animals) and asked to name as many items as you can 
think of that belong to that category.  There will be seven categories for you to name 
examples. This task will take about 25 minutes.  You will then be asked to complete two 
surveys.  The first will ask you about your general health right now, including your 
emotional health, physical health, and psychological state.  The second will ask you 
about how well you think you communicate.  The surveys will take about 30 minutes to 
complete.  You will receive breaks every hour or at any time that you wish during the 
time it takes you to complete these tasks.  
Participants Initials:____ 
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Your spoken responses in the sessions will be video recorded and typed-up.  Your 
name will not appear on the transcripts. Instead a pseudonym will be used.  All 
information collected for the study will be kept confidential.  If the results of the study are 
published, your name will not be used and no information that discloses you identity will 
be released or published without your consent or disclosure.  Representatives of 
Western University Health Sciences Research Ethics Board may require access to your 
study-related records or may follow up with you to monitor the conduct of the study. 
There are no known risks associated with the study beyond the discomfort that may 
arise when one reflects on one’s own life situation.  All tests will be given to you by 
trained personnel in a supportive, quiet, and comfortable environment in order to ease 
any potential discomfort from reflecting on your life situation.  You will be allowed to take 
breaks upon request if needed to ease any emotional distress.  You will also be video 
recorded.  All video recording equipment will be placed in a way to reduce any 
discomfort you may have.   
You may not get a personal benefit from participating in this study but your 
participation will advance the knowledge and care of individuals with ALS at large.  By 
taking part in this study, you will be providing information that may help to identify the  
types of support services that individuals with ALS require in the aim of improving ALS 
care.  Participation in this study is voluntary.  You may refuse to participate, refuse to 
answer any questions or withdraw from the study at any time.  If you are participating in 
Participants Initials:____ 
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another study at this time, please inform the student researcher asking you questions 
right away to determine if it is appropriate for you to participate in this study. 
 
If you have any questions about this study please contact Dr. J. B. Orange, 
Associate Professor, Western University. 
 
If you have any questions about the conduct of this study or your rights as a 
research subject you may contact Dr. David Hill, Scientific Director, Lawson Health 
Research Institute. 
 
This letter is yours to keep.  Please be aware that none of you legal rights are 
being waived by signing this consent form.  If you agree to participate in this study, 
please sign the consent form on the next page. 
 
 
 
 
 
 
 
Participant Initials:___ 
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Consent Forms 
Language Contributions to Health Related Quality of Life 
in Amyotrophic Lateral Sclerosis 
 
 I have read the Letter of Information, have had the nature of the study explained 
to me and I agree to participate in the research project entitled, “Language 
Contributions to Health Related Quality of Life in Amyotrophic Lateral Sclerosis”.  All 
questions have been answered to my satisfaction. 
Participant (Print Name) 
_________________________________ 
Signature of Participate     Date  
_______________________________             ____________________________ 
Individual Obtaining Consent (Print Name) 
________________________________   
Signature of Individual Obtaining Consent  Date 
___________________________________  ___________________________________ 
 
 
 
Participant’s Initials: ____ 
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Appendix B 
Assessment of Speech Intelligibility 
ALS and Health Related Quality of Life Study 
Katie Findlater and Professor JB Orange 
Randomized List: ____ 
 
Listener’s Name: ________________ Age: ____ Date: __________________ 
 
Self-Reported Hearing Issues: _____ Do you wear hearing aids?  Y / N  
 
Instructions: 
Please rank each of the 34 speech samples you will hear using the scale 
provided below.  The left side of the scale represents “Completely Intelligible” (normal) 
speech, while the right side of the scale represents “Completely Unintelligible” 
(profoundly disordered) speech.  The scale also indicates variations in the level of 
intelligibility according the following categories: 
 
MI = Mildly Unintelligible 
MO = Moderately Unintelligible 
SE = Severely Unintelligible 
  
Please mark your rating on the line using an X. You may mark the scale at any 
point along its length that you believe best corresponds to your judgment of the speech 
sample relative to what to you perceive to be the level of intelligibility.  Please consider 
the full range of possible scores.  
  
The speech sample that you will hear will vary in length and content.  However, it 
is important for you to make your judgments of intelligibility independent of the length 
and content across speech samples.  Your judgments should be based on how well you 
are able to understand the words and the speech sounds that the person is producing.  
Please make your ratings independently across the samples and from the other raters.  
There are no right or wrong answers.  This task will take approximately 60 minutes to 
complete.  Thank you for your participation. 
 
 Example:    
 
 
_________________________________________      
        MI                         MO                         SE 
 
 
 
 
 
 
Completely 
Intelligible 
Completely 
Unintelligible 
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Curriculum Vitae 
Katie Findlater 
 
Education  
 
Master of Clinical Sciences 
Acceptance to the program commencing September 2013 
Western University 
Speech-language pathology 
 
Master of Science             
Anticipated Completion- July 2013 
Western University, London, Ontario 
Health and Rehabilitation Sciences Program- Speech and Language Science Field 
Master’s Thesis: 
Language Contributions to Health Related Quality of Life in Amyotrophic Lateral 
Sclerosis 
 
Honors Bachelor of Science     
September 2007- June 2011 
Western University, London, Ontario  
Major Anatomy and Cell Biology, Major Biology  
 
Research Experience 
 
Research Assistant  
January 2010-September 2011 
Dr. J. B. Orange’s Communication and Aging Laboratory, Western University, London, 
Ontario 
• Transcribed data and did statistical analysis for academic journal publications 
• Provided support and follow up instructions for patients involved in clinical studies 
• Assisted graduate students in assessment and treatment of clinical research 
participants with Frontotemporal Dementia, Alzheimer’s Disease, Amyotrophic Lateral 
Sclerosis, Parkinson’s Disease, and other progressive neurological conditions  
 
 
Teaching Assistant Experience 
 
September 2011- December 2012 
Western University, London, Ontario 
 
Health Related Quality of Life (HS 3050A) - Fall 2012 
• Course designed to provide instruction related to comprehensive issues that 
underlie the conceptualization, definition, and measurement of what is termed 
“health--‐related quality of life” (HRQOL) or quality of Life (QOL).  The course is 
designed to introduce the student to comprehensive issues underlying HRQOL, 
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its measurement and utility as an outcomes metric, and the broad application of 
HRQOL in health care. 
Human Anatomy (Kin 2222/HS 2300) - Winter 2012 
• Course designed to provide students with a systemic description of the 
anatomical structure and function of the human body. This course describes the 
gross anatomy of the major systems, with emphasis on movement and 
locomotion as it pertains to the musculoskeletal, cardiovascular, and nervous 
systems. The other systems of the human body, namely digestive, respiratory, 
reproductive, urinary, with respect to how they (the systems) relate to the 
skeletal, muscular and cardiovascular systems are also covered. 
Communication Sciences and Disorders (CSD 4411) - Fall 2011 
• Course designed for students to gain a fundamental understanding of the types 
of speech, voice, swallowing, hearing, language, and cognitive-communication 
disorders seen by speech language pathologists, including the epidemiology, 
aetiology, symptomatology, assessment and treatment of these disorders in 
children and adults. 
 
Volunteer and Observation Experience 
 
Sponsored Learner  
December 2011- June 2012 
Speech and Language Pathology Department, University Hospital, London, Ontario 
• Provided volunteer services to Speech Language Pathologist’s in the Hospital 
• Provided research projects and articles for clinicians  
• Observed SLP’s during clinical rounds and in assessment and treatment sessions 
 
H.A. Leeper Speech and Hearing Clinic- Tyke Talk Clinic  
July 2011-December 2011  
Western University, London, Ontario 
• Observed treatments and assessments of children attending the Tyke talk clinic 
• Twenty-eight hours completed 
 
Audiology Observation 
March 2011 
Audiology Department, University Hospital, London, Ontario 
• Completed fourteen hours of observing numerous hearing tests, hearing aid fittings, 
and hearing assessment s in patients with cochlear implants, and a number of 
conductive hearing deficits 
 
Publications and Poster Presentations 
 
Findlater, K. M. Orange, J. B., Shoesmith, C., & Findlater K. A. (June 2013).  Language 
contributions to health related quality of life in ALS.  FTD-ALS Conference, 
London, Ontario. 
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changes in ALS. Seminars in Speech and Language, 33(1), 79-94. 
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Academy of Aphasia, Montreal, Canada.  
 
Awards and Certificates 
 
• Faculty of Health Science Travel Award, May 2013 
• Western Graduate Scholarship, September 2011- Present 
• Excellence in Leadership Award, Western University, 2011 
• Governor General Award, 2007  
• University of Western Ontario Entrance Scholarship, 2007 
• Canadian Autoworkers Union Scholarship, 2007 
• RMC “Old” Boys Scholarship, 2007 
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